<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Health Serv Res</journal-id><journal-id journal-id-type="iso-abbrev">BMC Health Serv Res</journal-id><journal-id journal-id-type="pmc-domain-id">34</journal-id><journal-id journal-id-type="pmc-domain">bmchsr</journal-id><journal-title-group><journal-title>BMC Health Services Research</journal-title></journal-title-group><issn pub-type="epub">1472-6963</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10536731</article-id><article-id pub-id-type="pmcid-ver">PMC10536731.1</article-id><article-id pub-id-type="pmcaid">10536731</article-id><article-id pub-id-type="pmcaiid">10536731</article-id><article-id pub-id-type="pmid">37770912</article-id><article-id pub-id-type="doi">10.1186/s12913-023-10028-2</article-id><article-id pub-id-type="publisher-id">10028</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Risk factors for medication-related short-term readmissions in adults &#8211; a scoping review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5530-8502</contrib-id><name name-style="western"><surname>Sch&#246;nenberger</surname><given-names initials="N">N.</given-names></name><address><email>nicole.schoenenberger@insel.ch</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3523-5729</contrib-id><name name-style="western"><surname>Meyer-Massetti</surname><given-names initials="C">C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, </institution><institution>Bern University Hospital, University of Bern, </institution></institution-wrap>Bern, Switzerland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02k7v4d05</institution-id><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>Graduate School for Health Sciences, </institution><institution>University of Bern, </institution></institution-wrap>Bern, Switzerland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02k7v4d05</institution-id><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>Institute of Primary Healthcare (BIHAM), </institution><institution>University of Bern, </institution></institution-wrap>Bern, Switzerland </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>9</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">424977</issue-id><elocation-id>1037</elocation-id><history><date date-type="received"><day>8</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>12</day><month>9</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>09</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>29</day><month>09</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-27 05:25:23.183"><day>27</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12913_2023_Article_10028.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Hospital readmissions due to medication-related problems occur frequently, burdening patients and caregivers emotionally and straining health care systems economically. In times of limited health care resources, interventions to mitigate the risk of medication-related readmissions should be prioritized to patients most likely to benefit. Focusing on general internal medicine patients, this scoping review aims to identify risk factors associated with drug-related 30-day hospital readmissions.</p></sec><sec><title>Methods</title><p id="Par2">We began by searching the Medline, Embase, and CINAHL databases from their inception dates to May 17, 2022 for studies reporting risk factors for 30-day drug-related readmissions. We included all peer-reviewed studies, while excluding literature reviews, conference abstracts, proceeding papers, editorials, and expert opinions. We also conducted backward citation searches of the included articles. Within the final sample, we analyzed the types and frequencies of risk factors mentioned.</p></sec><sec><title>Results</title><p id="Par3">After deduplication of the initial search results, 1159 titles and abstracts were screened for full-text adjudication. We read 101 full articles, of which we included 37. Thirteen more were collected via backward citation searches, resulting in a final sample of 50 articles. We identified five risk factor categories: (1) patient characteristics, (2) medication groups, (3) medication therapy problems, (4) adverse drug reactions, and (5) readmission diagnoses. The most commonly mentioned risk factors were polypharmacy, prescribing problems&#8212;especially underprescribing and suboptimal drug selection&#8212;and adherence issues. Medication groups associated with the highest risk of 30-day readmissions (mostly following adverse drug reactions) were antithrombotic agents, insulin, opioid analgesics, and diuretics. Preventable medication-related readmissions most often reflected prescribing problems and/or adherence issues.</p></sec><sec><title>Conclusions</title><p id="Par4">This study&#8217;s findings will help care teams prioritize patients for interventions to reduce medication-related hospital readmissions, which should increase patient safety. Further research is needed to analyze surrogate social parameters for the most common drug-related factors and their predictive value regarding medication-related readmissions.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12913-023-10028-2.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Drug-related readmissions</kwd><kwd>Drug-related problems</kwd><kwd>Adverse drug reactions</kwd><kwd>Medication safety</kwd><kwd>Hospital readmission</kwd><kwd>Scoping review</kwd><kwd>General internal medicine</kwd><kwd>Risk factors</kwd><kwd>Prediction</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par15">Hospital readmissions burden patients emotionally and increase healthcare systems&#8217; economic challenges [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. One prevalent medical intervention in general internal medicine is medication therapy, with regimens often initiated or changed during a hospital stay. As a result, shortly after patients are discharged, they experience new medication-related problems (MRPs) [<xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref>], i.e., &#8220;event[s] or circumstance[s] involving drug therapy that actually or potentially interfere with desired health outcomes&#8221; [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par16">MRPs can be either adverse drug reactions (ADRs) or medication errors (MEs). The latter encompass erroneous drug administration, incorrect dosages, unnecessary or omitted drug therapy (respectively over- or underprescribing), and non-adherence [<xref ref-type="bibr" rid="CR7">7</xref>]. When severe, MRPs can lead to hospital readmissions. For example, too high a dose of diuretics can cause an excessive drop in blood pressure, precipitating a fall, which may require hospitalization.</p><p id="Par17">Of the many thresholds used for readmission times, 30 days is the most common [<xref ref-type="bibr" rid="CR8">8</xref>]. This is likely because the Centers for Medicare and Medicaid Services (CMS) penalize health institutions financially for higher-than-expected 30-day readmission rates [<xref ref-type="bibr" rid="CR9">9</xref>]. Whatever the threshold, though, both to improve patient safety and reduce avoidable health care expenditures, it is vital to minimize preventable readmissions.</p><p id="Par18">A substantial proportion of readmissions are for MRPs. A 2018 systematic review found that the median prevalence of medication-related readmissions (MRRs) was 21% of all readmissions [<xref ref-type="bibr" rid="CR10">10</xref>]. Of those MRRs, 69% were deemed potentially preventable [<xref ref-type="bibr" rid="CR10">10</xref>]. Various studies have reported MRR risk factors [<xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>]. In addition to ADRs and MEs, these can include combinations of factors such as polypharmacy and increased patient age [<xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>]. However, no previous study has set out to synthesize evidence on MRR risk factors by means of a literature review in a general internal medicine population as their primary objective. El Morabet et al. [<xref ref-type="bibr" rid="CR10">10</xref>] conducted a systematic literature review to determine the prevalence and preventability of MRRs. And while they did provide a summary of reported risk factors retrospectively, they did not prospectively search for them. Another study by Linkens et al. [<xref ref-type="bibr" rid="CR16">16</xref>] provided an overview of the literature on risk factors for medication-related admissions and MRRs. However, this study only searched one bibliographic database and did not clearly distinguish between risk factors for medication-related admissions and MRRs [<xref ref-type="bibr" rid="CR16">16</xref>]. Additionally, both studies [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] did not focus on short-term readmissions. As this knowledge gap about short-term MRRs has expensive and burdensome consequences, the purpose of the current scoping review is to provide an overview of risk factors linked to medication-related 30-day hospital readmissions in a general internal medicine department&#8217;s adult population. Identifying such risk factors is essential to helping hospitals target patients most likely to benefit from relevant interventions.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design</title><p id="Par19">Combined with the Arskey and O&#8217;Malley framework [<xref ref-type="bibr" rid="CR17">17</xref>], the Joanna Briggs Institute&#8217;s recommendations [<xref ref-type="bibr" rid="CR18">18</xref>] for conducting scoping studies guided our literature review. For our writing, we applied the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist [<xref ref-type="bibr" rid="CR19">19</xref>]. The review protocol was not published separately, but is available upon request from the corresponding author.</p></sec><sec id="Sec4"><title>Eligibility criteria</title><p id="Par20">We conducted a thorough review of the existing literature on risk factors for medication-related readmissions within 30 days of hospital discharge. The outcome of interest was 30-day readmissions, which encompassed both readmissions to the same hospital and readmissions to a different hospital, if reported accordingly. Additionally, we focused on reporting medication-related risk factors associated with these readmissions. This review included studies reporting one or more of the following factors and their association with short-term readmissions: (1) specific medications or medication groups; (2) patient characteristics or sociodemographic characteristics associated with readmissions caused by MRPs; (3) medication therapy characteristics or problems; and (4) readmission diagnoses of MRRs.</p><p id="Par21">We excluded studies where no medication-related attributes are reported, where readmissions to other institutions than hospitals are analyzed, or where the time-to-readmission threshold is longer than 30 days&#8212;our timeframe of interest. Additionally, we excluded studies that analyze readmissions in patients&#8201;&lt;&#8201;18 years of age. Studies focusing on patients discharged from hospital departments other than general internal medicine, including but not limited to surgery, transplant, or oncology departments, were also excluded. Likewise, we did not consider studies that focus solely on specific patient populations (e.g., heart failure patients) or medication groups (e.g., diuretics). As we did not assess each included study&#8217;s bias risk and were interested in original research, we excluded conference abstracts, proceeding papers, editorials, expert opinions, reviews, and any papers for which full-text versions are not available. As the researchers are fluent in English, German, and French, studies in those languages were included; those published in other languages were excluded.</p></sec><sec id="Sec5"><title>Information sources, search strategy</title><p id="Par22">We searched the MEDLINE (inception year: 1946), Embase (inception year: 1974), and CINAHL (inception year: 1961) databases using Ovid for the first two and EBSCO for the last. We searched the entire databases until the dates of our searches, the last of which was conducted on May 17<sup>th</sup> 2022. For included studies and literature reviews with research questions similar to ours [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], we also conducted manual backward citation searches.</p><p id="Par23">We combined and searched subject headings (SHs) for <italic toggle="yes">readmissions</italic>, <italic toggle="yes">MEs</italic> or <italic toggle="yes">ADRs</italic>, and <italic toggle="yes">risk factors</italic> or <italic toggle="yes">risk assessment</italic>. Additionally, we searched titles and abstracts for these SHs (and synonyms), as well as <italic toggle="yes">medication groups</italic> (and synonyms) in abstracts and titles (no SHs available), combined with the index term <italic toggle="yes">readmission</italic> (and its synonyms) in abstracts and titles. All search strings for title and abstract fields were constructed to account for any alternative spellings.</p><p id="Par24">The search strategy was discussed and optimized with a medical librarian. The strategies used in the individual databases are provided in Supplementary File&#160;<xref rid="MOESM1" ref-type="media">1</xref>. No limits were applied to the searches regarding language or date of publication. In Ovid Embase, the records were filtered to exclude conference materials. Records were deduplicated using EndNote 20 (2013, Clarivate, Philadelphia, USA) and manually&#8212;by finding and deleting duplicates&#8212;using Microsoft Excel (2016, Microsoft, Redmond, USA).</p></sec><sec id="Sec6"><title>Study selection, data extraction, and synthesis of results</title><p id="Par25">Two reviewers independently screened the retrieved records&#8217; titles and abstracts for eligibility. In a second step, potentially eligible records&#8217; full texts were reviewed for inclusion. Disagreements at both stages were solved through personal communication.</p><p id="Par26">From the included studies, one reviewer collected data, which were then verified by the second author. Relevant data items were entered to a predefined table. In a second step, this table was summarized and aggregated, where factors and certain study characteristics could be checked off, filled in with numbers or answered with dichotomous outcomes.</p><p id="Par27">The first table (Supplementary File&#160;<xref rid="MOESM2" ref-type="media">2</xref>) presented eight data fields: publication year, country of origin, study type, study site, study population, whether readmissions' causality or preventability were analyzed, objectives, and readmission rates (if analyzed and reported). To ensure comparability across the included studies, readmission rates were calculated as percentages by dividing the absolute number of reported readmissions by the total number of studied admissions. This calculation was performed only for studies that did not already report the readmission rates as percentage values. The main part of the first table lists medication relevant factors (i.e., patient characteristics, medication group or medication therapy characteristics and problems associated with MRRs). Where medication groups or specific active substances are listed, we have added the Anatomical Therapeutic Chemical (ATC) classification system codes in square brackets. The aggregated table (Supplementary File&#160;<xref rid="MOESM3" ref-type="media">3</xref>) contains the following information: whether age or number of medications taken were preselected in the studied population; whether the study uses a readmission risk stratification model; whether causality and/or preventability is assessed; and follow-up time in days. Additionally, we have added a row for each factor and headed it with that factor&#8217;s name. As the studies are listed in columns, we have inserted a check-box in the corresponding cell to indicate each factor's presence. If a particular risk factor is connected with a preventable readmission, a P is included in superscript. If the study classifies&#8201;&#8805;&#8201;50% of readmissions including a particular risk factor as preventable, a &#8220;(P)&#8221; is added in superscript. Causality of the readmission was considered established if a validated tool like the Naranjo scale [<xref ref-type="bibr" rid="CR20">20</xref>] or the AT-HARM 10 criteria [<xref ref-type="bibr" rid="CR21">21</xref>] was utilized, or if physician judgment, such as through a coded ADR, was used to classify the readmission due to a medication-related problem. Conversely, no causality was assumed if the studies examined all-cause 30-day readmissions and identified, e.g., a higher prevalence of certain medication groups in the readmitted group compared to the non-readmitted group. In the all-cause readmissions, we only extracted data connected with medications (i.e., medication groups, or number of medications, being dependent on help with medications etc.). This means that in this scoping review, causality refers to whether the included studies analyzed if the identified risk factor (e.g., a certain medication) was justifiably the reason for the readmission.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par28">After deduplication, we retrieved 1159 publications. We excluded 1058 studies through title and abstract screening, mostly because no risk factors for MRRs were reported or only in specific patient populations. Subsequently, we retrieved 101 full-text studies to analyze eligibility. Of these, we included 37. Through backward citation searches, we additionally retrieved 53 full texts, of which 13 proved eligible, pushing the sample size up to 50 publications. A flow diagram of the literature review process is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>PRISMA 2020 [<xref ref-type="bibr" rid="CR19">19</xref>] flow diagram. Abbreviations: n, number</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12913_2023_10028_Fig1_HTML.jpg"/></fig></p><p id="Par29">An overview of the included studies is provided in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Overview of included studies</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="1" rowspan="1">Studies</td><td align="left" colspan="1" rowspan="1"><bold>Uitvlugt, E. B., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Cooper, J. B., et al. (2020)</bold> [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Whitaker, A. S., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Dalleur, O., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Dreyer, R., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td align="left" colspan="1" rowspan="1">Yam, C. H., et al. (2010) [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left" colspan="1" rowspan="1">Frankl, S. E., et al. (1991) [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Toh, M. R., et al. (2014) </bold>[<xref ref-type="bibr" rid="CR26">26</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Willson, M. N., et al. (2014)</bold> [<xref ref-type="bibr" rid="CR27">27</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Banholzer, S., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Nikolaus, T., et al. (1992)</bold> [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Ekerstad, N., et al. (2017)</bold> [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Rothwell, M., et al. (2011)</bold> [<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Age</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">Geri</td><td align="left" colspan="1" rowspan="1">75&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Number of medications</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">3&#8201;+&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">Model</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td></tr><tr><td align="left" colspan="1" rowspan="1">Causality (medication-related)</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td></tr><tr><td align="left" colspan="1" rowspan="1">Preventability</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up time [days]</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">28</td></tr><tr><td align="left" colspan="1" rowspan="1">Country</td><td align="left" colspan="1" rowspan="1">NL</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">AU</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">ZA</td><td align="left" colspan="1" rowspan="1">CN</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">SG</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">CH</td><td align="left" colspan="1" rowspan="1">DE</td><td align="left" colspan="1" rowspan="1">SE</td><td align="left" colspan="1" rowspan="1">AU</td></tr><tr><td align="left" colspan="1" rowspan="1">Readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">10.5</td><td align="left" colspan="1" rowspan="1">16.9</td><td align="left" colspan="1" rowspan="1">12.5</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">24.6</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">40.8</td><td align="left" colspan="1" rowspan="1">8.6</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">MRRs on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">50.2</td><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">13.1</td><td align="left" colspan="1" rowspan="1">12.6</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">15.9</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">20.9</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">33.3</td><td align="left" colspan="1" rowspan="1">23</td></tr><tr><td align="left" colspan="1" rowspan="1">Potentially preventable MRRs on total MRRs [%]</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">57.8</td><td align="left" colspan="1" rowspan="1">59</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">11.9</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">13.8</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">65.6</td><td align="left" colspan="1" rowspan="1">87</td></tr><tr><td align="left" colspan="1" rowspan="1">Studies</td><td align="left" colspan="1" rowspan="1"><bold>Beckner, A., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td align="left" colspan="1" rowspan="1">Allaudeen, N., et al. (2011) [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td align="left" colspan="1" rowspan="1">Rosen, O. Z., et al. (2017) [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td align="left" colspan="1" rowspan="1">Logue, E., et al. (2016) [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Lau, M. H. M., et al. (2017)</bold> [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Pavon, J. M., et al. (2014)</bold> [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Ibarra Mira, M. L., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Pereira, F., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Basnet, S., et al. (2018)</bold> [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Lohman, M. C., et al. (2017) </bold>[<xref ref-type="bibr" rid="CR51">51</xref>]</td><td align="left" colspan="1" rowspan="1">Schoonover, H., et al. (2014) [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td align="left" colspan="1" rowspan="1">Anderson, R. E., et al. (2016) [<xref ref-type="bibr" rid="CR53">53</xref>]</td><td align="left" colspan="1" rowspan="1">Blanc, A. L., et al. (2019) [<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Age</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">75&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">60&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">50&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Number of medications</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">5&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">5&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Model</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">Y</td></tr><tr><td align="left" colspan="1" rowspan="1">Causality (medication-related)</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td></tr><tr><td align="left" colspan="1" rowspan="1">Preventability</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">Y</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up time [days]</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td></tr><tr><td align="left" colspan="1" rowspan="1">Country</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">CN</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">ES</td><td align="left" colspan="1" rowspan="1">CH</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">CH</td></tr><tr><td align="left" colspan="1" rowspan="1">Readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">14.7</td><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">25.5</td><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">25.6</td><td align="left" colspan="1" rowspan="1">7.8</td><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">14.6</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">21.8</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">7.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">MRRs on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Potentially preventable MRRs on total MRRs [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Studies</td><td align="left" colspan="1" rowspan="1">Witherington, E. M., et al. (2008) [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Weir, D. L., et al. (2020)</bold> [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Glans, M., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Schwab, C., et al. (2018)</bold> [<xref ref-type="bibr" rid="CR33">33</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Barnett, N. L., et al. (2017)</bold> [<xref ref-type="bibr" rid="CR34">34</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Koekkoek, D., et al. (2011)</bold> [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Balla, U., et al. (2008)</bold> [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td align="left" colspan="1" rowspan="1">Feigenbaum, P., et al. (2012) [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Classen, D. C., et al. (2010)</bold> [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Porter, M., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Wetherell, M., et al. (2017)</bold> [<xref ref-type="bibr" rid="CR40">40</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Aljishi, M., et al. (2014)</bold> [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Age</td><td align="left" colspan="1" rowspan="1">75&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">75&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Number of medications</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">1&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Model</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Causality (medication-related)</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preventability</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up time [days]</td><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Country</td><td align="left" colspan="1" rowspan="1">GB</td><td align="left" colspan="1" rowspan="1">CA</td><td align="left" colspan="1" rowspan="1">SE</td><td align="left" colspan="1" rowspan="1">FR</td><td align="left" colspan="1" rowspan="1">GB</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">IL</td><td align="left" colspan="1" rowspan="1">CA</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">NZ</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">35.4</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">6.4</td><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">14.1</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">46.2</td><td align="left" colspan="1" rowspan="1">10.7</td><td align="left" colspan="1" rowspan="1">4.97</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">47</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">MRRs on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">38</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">11.4</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Potentially preventable MRRs on total MRRs [%]</td><td align="left" colspan="1" rowspan="1">61</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">1.7</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Studies</td><td align="left" colspan="1" rowspan="1">McAuliffe, L. H., et al. (2018) [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Sorensen, A., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR56">56</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Fung, L., et al. (2020)</bold> [<xref ref-type="bibr" rid="CR57">57</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Trautwein, M., et al. (2020)</bold> [<xref ref-type="bibr" rid="CR58">58</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Criddle, D. T., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR59">59</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Picker, D., et al. (2015)</bold> [<xref ref-type="bibr" rid="CR60">60</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Nguyen, H. L., et al. (2022)</bold> [<xref ref-type="bibr" rid="CR61">61</xref>]</td><td align="left" colspan="1" rowspan="1">Dorajoo, S. R., et al. (2017) [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>SanFilippo, S., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR63">63</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Leffler, M. E., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR64">64</xref>]</td><td align="left" colspan="1" rowspan="1"><bold>Sieck, C., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR65">65</xref>]</td><td align="left" colspan="1" rowspan="1">Meldon, S. W., et al. (2003) [<xref ref-type="bibr" rid="CR66">66</xref>]</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Age</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">65&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preselection: Number of medications</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">5&#8201;+&#8201;</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Model</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Causality (medication-related)</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preventability</td><td align="left" colspan="1" rowspan="1">Y</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up time [days]</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Country</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">AU</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">SG</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1">US</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">21.4</td><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">12.6</td><td align="left" colspan="1" rowspan="1">25.9</td><td align="left" colspan="1" rowspan="1">20.8</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">31.9</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total admissions [%]</td><td align="left" colspan="1" rowspan="1">14.8</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Preventable readmissions on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">MRRs on total readmissions [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Potentially preventable MRRs on total MRRs [%]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>Studies identified through databases are depicted in bold, those identified through citation searches in regular type</p><p><italic toggle="yes">Abbreviations</italic>: <italic toggle="yes">N</italic> No, <italic toggle="yes">Y</italic> Yes, <italic toggle="yes">Geri</italic> Geriatric population, <italic toggle="yes">MRR</italic> Medication-related readmissions, <italic toggle="yes">NL</italic> Netherlands, <italic toggle="yes">US</italic> United States, <italic toggle="yes">AU</italic> Australia, <italic toggle="yes">ZA</italic> South Africa, <italic toggle="yes">CN</italic> China, <italic toggle="yes">SG</italic> Singapore, <italic toggle="yes">CH</italic> Switzerland, <italic toggle="yes">DE</italic> Germany, <italic toggle="yes">SE</italic> Sweden, <italic toggle="yes">GB</italic> United Kingdom, <italic toggle="yes">IL</italic> Israel, <italic toggle="yes">CA</italic> Canada, NZ New Zealand, <italic toggle="yes">ES</italic> Spain</p></table-wrap-foot></table-wrap></p><p id="Par30">Studies identified through database searches are shown in bold; those identified through citation searches are in regular text. Of the included studies, 18 assess causality [<xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref>], particularly specifying whether the readmissions were caused by MRPs. The other 32 [<xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>] examine medication-associated factors (e.g., whether readmitted patients were more likely to have had polypharmacy), but do not establish whether the readmissions were caused by MRPs. Fourteen studies describe risk prediction models [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR54">54</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>]. In 19, the study population was preselected based on advanced age (most often&#8201;&#8805;&#8201;65 years (<italic toggle="yes">n</italic>&#8201;=&#8201;11)) and/or number of medications taken [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR46">46</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR63">63</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>]. Specifically, 14 preselected their participants based on age [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR64">64</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>], one based on number of medications [<xref ref-type="bibr" rid="CR48">48</xref>], and four based on a combination of age and number of medications [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. The readmissions&#8217; preventability was analyzed in 17 publications [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR34">34</xref>&#8211;<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. The most common readmission time threshold (<italic toggle="yes">n</italic>&#8201;=&#8201;42, 84%) is 30 days [<xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR63">63</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>], followed by 28 days (<italic toggle="yes">n</italic>&#8201;=&#8201;4, 8%) [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Two studies each examine 21-day [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] and 15-day readmissions (4% each) [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Most studies (<italic toggle="yes">n</italic>&#8201;=&#8201;27) were conducted in the US [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR38">38</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR63">63</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>]. The comprehensive table with all extracted characteristics can be found in Supplementary File&#160;<xref rid="MOESM2" ref-type="media">2</xref>.</p><sec id="Sec8"><title>Primary outcomes</title><p id="Par31">For the sake of clarity, only MRR risk factors mentioned by at least three included studies are presented in this manuscript. A table of all factors, indicating which studies reported them, can be found in Supplementary File&#160;<xref rid="MOESM3" ref-type="media">3</xref>. The results&#8217; section is divided into three parts: in the first and main part, we include the findings of studies assessing the causality of the readmissions, in the second part, we highlight differences, if the findings are combined with non-causality studies; and in the third and last part, we provide an insight into medication-related risk factors for preventable readmissions.</p></sec><sec id="Sec9"><title>Patient characteristics &#8211; studies establishing causality</title><p id="Par32">Twelve of the included 18 studies, that assessed causality, mentioned medication-relevant patient characteristics [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR26">26</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref>]. Regarding studies that preselected their study populations based on older age or higher numbers of medications, we included these criteria as risk factors. Advanced age (most often&#8201;&#8805;&#8201;65 years) is the patient characteristic that most commonly accompanies MRRs (mentioned in eight studies) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>]. Seven mention polypharmacy and/or specific number of drugs as risk factors [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Three causality studies define the number of medications considered polypharmacy, the most common threshold is&#8201;&#8805;&#8201;10 (<italic toggle="yes">n</italic>&#8201;=&#8201;2) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Three studies highlight the number of changes in patients&#8217; medication regimens during their initial hospital stay as factors associated with increased MRR rates [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec10"><title>Medication groups &#8211; studies establishing causality</title><p id="Par33">Ten studies mention specific medication groups that caused readmissions [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Antithrombotics are mentioned most frequently (<italic toggle="yes">n</italic>&#8201;=&#8201;9) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], especially anticoagulants (<italic toggle="yes">n</italic>&#8201;=&#8201;7) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. These are followed by antidiabetics (<italic toggle="yes">n</italic>&#8201;=&#8201;8) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], particularly insulin [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Diuretics were also mentioned eight times [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Antibacterials (<italic toggle="yes">n</italic>&#8201;=&#8201;7) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] and opioid analgesics (<italic toggle="yes">n</italic>&#8201;=&#8201;6) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] were also frequently noted. An exhaustive list of the medication groups mentioned by at least three of the included studies is shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. In Table&#160;<xref rid="Tab2" ref-type="table">2</xref>, ten studies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] assessed causality, whereas the remaining 11 studies [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>] investigated all-cause readmissions and reported that particular medication groups were associated with a higher readmission rate.
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Medication groups associated with readmissions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Studies</bold></th><th align="left" colspan="1" rowspan="1"><bold>Uitvlugt, E. B., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR14">14</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Cooper, J. B., et al. (2020)</bold> [<xref ref-type="bibr" rid="CR22">22</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Dalleur, O., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR12">12</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Dreyer, R., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR23">23</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Frankl, S. E., et al. (1991)</bold> [<xref ref-type="bibr" rid="CR25">25</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Banholzer, S., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR11">11</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Nikolaus, T., et al. (1992)</bold> [<xref ref-type="bibr" rid="CR28">28</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Ekerstad, N., et al. (2017)</bold> [<xref ref-type="bibr" rid="CR29">29</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Rothwell, M., et al. (2011)</bold> [<xref ref-type="bibr" rid="CR30">30</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Barnett, N. L., et al. (2017)</bold> [<xref ref-type="bibr" rid="CR34">34</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Koekkoek, D., et al. (2011)</bold> [<xref ref-type="bibr" rid="CR35">35</xref>]</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Laxatives [A06A]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antidiabetics [A10]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Insulin [A10A]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Oral antidiabetics [A10B]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mineral supplements [A12]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antithrombotic agents [B01]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anticoagulants [B01AA, B01AB, B01AF, B01AX]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Vitamin K antagonists [B01AA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Warfarin [B01AA03]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Heparin group [B01AB]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antiplatelets excl. heparins [B01AC]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Acetyl salicylic acid [B01AC06]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Cardiac glycosides [C01AA]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Digoxin [C01AA05]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antiarrhythmic agents [C01B]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Vasodilator [C01D, C04]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antihypertensives [C02, C03, C07, C08, C09]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Diuretics [C03]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Saluretics [C03A, C03B, C03C, C03D, C03E]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Sympatholytics [C02A, C02B, C02C, C07]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Beta-blocking agents [C07A]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Calcium channel blocker [C08]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Agents acting on renin-angiotensin system [C09]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;ACE inhibitors [C09AA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Corticosteroids [H02]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antibacterial for systemic use [J01]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antineoplastic agents [L01]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Immunosuppressants [L04]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Analgesics [N02]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Opioids and drugs used against addiction [N02A]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Antiepileptics [N03A]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hydantoin derivatives [N03AB]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Carboxamide derivatives [N03AF]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Psycholeptics [N05]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hypnotics and sedatives [N05C]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anxiolytics [N05B]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Benzodiazepine based tranquillizers [N05BA/N05CD/N05CF]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Benzodiazepine derivatives [N05BA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Psychoanaleptics [N06]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antidepressants [N06A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">NSAIDs [M01A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Medications for obstructive airway diseases (asthma/COPD) [R03]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Studies</bold></th><th align="left" colspan="1" rowspan="1"><bold>Classen, D. C., et al. (2010)</bold> [<xref ref-type="bibr" rid="CR38">38</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Allaudeen, N., et al. (2011)</bold> [<xref ref-type="bibr" rid="CR43">43</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Pavon, J. M., et al. (2014)</bold> [<xref ref-type="bibr" rid="CR47">47</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Pereira, F., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR49">49</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Blanc, A. L., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR54">54</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Fung, L., et al. (2020)</bold> [<xref ref-type="bibr" rid="CR57">57</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Criddle, D. T., et al. (2021)</bold> [<xref ref-type="bibr" rid="CR59">59</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Nguyen, H. L., et al. (2022)</bold> [<xref ref-type="bibr" rid="CR61">61</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Leffler, M. E., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR64">64</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Sieck, C., et al. (2019)</bold> [<xref ref-type="bibr" rid="CR65">65</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Quantity mentioned</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Laxatives [A06A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antidiabetics [A10]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>14</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Insulin [A10A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>11</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Oral antidiabetics [A10B]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Mineral supplements [A12]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antithrombotic agents [B01]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>15</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anticoagulants [B01AA, B01AB, B01AF, B01AX]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>12</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Vitamin K antagonists [B01AA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>7</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Warfarin [B01AA03]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>6</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Heparin group [B01AB]</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antiplatelets excl. heparins [B01AC]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>7</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Acetyl salicylic acid [B01AC06]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Cardiac glycosides [C01AA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Digoxin [C01AA05]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antiarrhythmic agents [C01B]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Vasodilator [C01D, C04]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antihypertensives [C02, C03, C07, C08, C09]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>11</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Diuretics [C03]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>11</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Saluretics [C03A, C03B, C03C, C03D, C03E]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Sympatholytics [C02A, C02B, C02C, C07]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>7</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Beta-blocking agents [C07A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>7</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Calcium channel blocker [C08]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>6</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Agents acting on renin-angiotensin system [C09]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>6</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;ACE inhibitors [C09AA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Corticosteroids [H02]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>8</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antibacterial for systemic use [J01]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>7</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antineoplastic agents [L01]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Immunosuppressants [L04]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>8</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Analgesics [N02]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>15</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Opioids and drugs used against addiction [N02A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"><bold>14</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Antiepileptics [N03A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>8</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hydantoin derivatives [N03AB]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Carboxamide derivatives [N03AF]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Psycholeptics [N05]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>8</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hypnotics and sedatives [N05C]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anxiolytics [N05B]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Benzodiazepine based tranquillizers [N05BA/N05CD/N05CF]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Benzodiazepine derivatives [N05BA]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Psychoanaleptics [N06]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antidepressants [N06A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">NSAIDs [M01A]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Medications for obstructive airway diseases (asthma/COPD) [R03]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr></tbody></table><table-wrap-foot><p>ATC code(s) of the medications are in square brackets</p><p><italic toggle="yes">Abbreviations</italic>: <italic toggle="yes">ACE</italic> Angiotensin converting enzyme, <italic toggle="yes">COPD</italic> Chronic obstructive pulmonary disease, <italic toggle="yes">NSAIDs</italic> non-steroidal anti-inflammatory drugs</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Medication groups associated with adverse drug reactions leading to readmissions &#8211; studies establishing causality</title><p id="Par34">Ten studies describe ADRs leading to rehospitalizations [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Results indicate that ADRs involving antithrombotic agents, especially vitamin K antagonists, which are anticoagulants, were most often associated with readmissions due to ADRs [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Adverse reactions to antibacterial agents are also noted in three of the included studies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p></sec><sec id="Sec12"><title>Medication therapy problems excluding adverse drug reactions &#8211; studies establishing causality</title><p id="Par35">Fifteen records study medication therapy problems other than ADRs as reasons for readmissions [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. MRR-associated medication therapy problems are most commonly adherence issues (<italic toggle="yes">n</italic>&#8201;=&#8201;13) [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] and prescribing problems (<italic toggle="yes">n</italic>&#8201;=&#8201;12) [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. If a reason is given for suboptimal medication adherence, it is usually either erratic use [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] or difficulty using a specific dosage form [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. The most relevant prescribing problem is misprescribing (<italic toggle="yes">n</italic>&#8201;=&#8201;10) [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], most commonly either underdose (<italic toggle="yes">n</italic>&#8201;=&#8201;6) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] or overdose (<italic toggle="yes">n</italic>&#8201;=&#8201;6) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], drug-drug interactions (<italic toggle="yes">n</italic>&#8201;=&#8201;4) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], or suboptimal medication selection [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Another misprescribing problem mentioned in three studies was the prescription of a contraindicated medication [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Misprescribing problems are followed by underprescribing (<italic toggle="yes">n</italic>&#8201;=&#8201;9) [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>]. Overprescribing is a risk factor mentioned by five studies [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]; however, fewer MRRs are attributed to it compared to underprescribing. Insufficient ambulatory monitoring of medication therapy was mentioned six times [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], whereas transition of care errors were mentioned five times [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec13"><title>Readmission diagnoses &#8211; studies establishing causality</title><p id="Par36">Seven publications report MRR diagnoses [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Hypotension is the readmission diagnosis encountered most often (<italic toggle="yes">n</italic>&#8201;=&#8201;5) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. This is followed by myeolsuppression (including diagnoses of anemia, neutropenia, and/or thrombocytopenia) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], constipation [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], hypoglycemia [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], and bleeding [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], each mentioned by four studies. Arrhythmia (including atrial fibrillation) or QT prolongation was encountered three times [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In four, suboptimal patient monitoring or education about antithrombotic agents led to bleeding [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] and overprescribing or overdose of antihypertensives to hypotension [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Allergy or rash [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], infection [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], falls [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], or heart failure [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] were each named in three studies as reasons behind MRRs.</p></sec><sec id="Sec14"><title>Differences in medication-related risk factors between studies establishing causality and studies that do not</title><p id="Par37">With regard to patient characteristics, the results did not differ significantly when adding studies not establishing causality to the analysis. Twenty-four studies, not establishing causality, reported on medication-related patient characteristics that were linked with a higher rate of 30-day all-cause readmissions [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR48">48</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR62">62</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>]. Of these, 19 studies showed a higher readmission rate in patients with polypharmacy [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR62">62</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>]. Five studies highlight the prescription of potentially inappropriate medications (PIMs) [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] and an additional one the number of medication changes [<xref ref-type="bibr" rid="CR35">35</xref>] as factors associated with increased readmission rates. Finally, three studies correlate increased readmission rates with high medication regimen complexity index (MRCI) scores [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].</p><p id="Par38">In line with patient characteristics, when considering the 11 non-causality studies that reported on medication groups associated with readmissions [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>], the results did not change much: most frequently mentioned medication groups were still very prominent. Only antibacterials were not mentioned in non-causality studies. The detailed results for all the medication groups are shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.</p><p id="Par39">Four non-causality studies were included that reported on medication therapy problems excluding ADRs [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. ADR-specific analyses were not included in non-causality studies. Readmission diagnoses in connection with medications associated with readmission were cited in one non-causality study [<xref ref-type="bibr" rid="CR61">61</xref>]. Therefore, the results described above only change slightly, and we refer to the Supplementary File&#160;<xref rid="MOESM3" ref-type="media">3</xref> for details.</p></sec><sec id="Sec15"><title>Readmission rates and preventability</title><p id="Par40">All-cause readmission rates are reported by 29 of the included studies (see Table&#160;<xref rid="Tab1" ref-type="table">1</xref>), with a mean rate of 18.34&#8201;&#177;&#8201;8.78%. When three publications assessed what proportion of these readmissions were potentially preventable, they arrived at a cross-study mean of 32.13&#8201;&#177;&#8201;16.83%. Two also analyzed the rate of potentially preventable readmissions on total admissions (including readmissions), finding a mean of 11.15&#8201;&#177;&#8201;3.65%. The percentage of total readmissions classed as MRRs was analyzed by 13 studies, with an overall mean of 24.26&#8201;&#177;&#8201;11.76%; and across nine studies, the mean percentage of all MRRs that were potentially preventable is 44.2&#8201;&#177;&#8201;27.42%.</p><p id="Par41">Readmission preventability is investigated directly in 14 studies [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#8211;<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR37">37</xref>]. Three others describe risk prediction models targeted at preventable readmissions [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Regarding our listing of the various studies&#8217; factors (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>), as one of those predictive models&#8212;by Barnett et al. [<xref ref-type="bibr" rid="CR34">34</xref>]&#8212;does not specify which factors are predictive of preventable MRRs (i.e., no validation), we did not classify any of their listed factors as preventable. Similarly, as Dreyer et al. [<xref ref-type="bibr" rid="CR23">23</xref>] could not identify medication-related risk factors associated with readmission preventability in&#8201;&#8805;50% of cases, we also omitted these data. Respective drug groups, MRPs, and readmission diagnoses associated with preventable readmissions are tabulated in Table&#160;<xref rid="Tab3" ref-type="table">3</xref>. Ten of the included studies assessed causality [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>] of the readmissions, whereas four of them did not [<xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Factors associated with preventable readmissions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Studies</bold></th><th align="left" colspan="1" rowspan="1"><bold>Uitvlugt, E. B., et al. (2021) </bold> [<xref ref-type="bibr" rid="CR14">14</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Cooper, J. B., et al. (2020) </bold> [<xref ref-type="bibr" rid="CR22">22</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Whitaker, A. S., et al. (2019) </bold> [<xref ref-type="bibr" rid="CR15">15</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Dalleur, O., et al. (2021) </bold> [<xref ref-type="bibr" rid="CR12">12</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Yam, C. H., et al. (2010) </bold> [<xref ref-type="bibr" rid="CR24">24</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Frankl, S. E., et al. (1991) </bold> [<xref ref-type="bibr" rid="CR25">25</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Nikolaus, T., et al. (1992) </bold> [<xref ref-type="bibr" rid="CR28">28</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Ekerstad, N., et al. (2017) </bold> [<xref ref-type="bibr" rid="CR29">29</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Rothwell, M., et al. (2011) </bold> [<xref ref-type="bibr" rid="CR30">30</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Witherington, E. M., et al. (2008) </bold> [<xref ref-type="bibr" rid="CR31">31</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Koekkoek, D., et al. (2011) </bold> [<xref ref-type="bibr" rid="CR35">35</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Balla, U., et al. (2008) </bold> [<xref ref-type="bibr" rid="CR36">36</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Feigenbaum, P., et al. (2012) </bold> [<xref ref-type="bibr" rid="CR37">37</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Blanc, A. L., et al. (2019) </bold> [<xref ref-type="bibr" rid="CR54">54</xref>]</th><th align="left" colspan="1" rowspan="1"><bold>Quantity mentioned</bold></th></tr></thead><tbody><tr><td align="left" colspan="16" rowspan="1"><bold>Drug groups</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antidiabetics [A10]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Insulin [A10A]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antithrombotic agents [B01]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Anticoagulants [B01AA, B01AB, B01AF, B01AX]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antiplatelets excl. heparins [B01AC]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Acetyl salicylic acid [B01AC06]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Cardiac glycosides [C01AA]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Vasodilator [C01D, C04]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antihypertensives [C02, C03, C07, C08, C09]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Diuretics [C03]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Sympatholytics [C02A, C02B, C02C, C07]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;&#8195;Beta-blocking agents [C07A]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Agents acting on renin-angiotension system [C09]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Antibacterial for systemic use [J01]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Analgesics [N02]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Opioids and drugs used against addiction [N02A]</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="16" rowspan="1"><bold>Medication-related problems except adverse drug reactions</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Prescribing problems</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>10</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Overprescribing ("no indication")</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Underprescribing ("indication but no drug")</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>9</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Misprescribing ("indication but suboptimal drug prescribing)</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>8</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Wrong dose</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;&#8195;Overdose</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;&#8195;Underdose</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>4</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Suboptimal therapy/drug selection</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Adherence issues</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>8</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Insufficient ambulatory monitoring</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Transition errors</td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>5</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Incomplete medication discharge information</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Adverse drug reactions</bold></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>(P)</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="16" rowspan="1"><bold>Readmission Diagnosis</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Arrhythmia (including atrial fibrilation) or QT prolongation</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Heart failure</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Infection</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1">X<sup>P</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"><bold>3</bold></td></tr></tbody></table><table-wrap-foot><p>ATC code(s) of the medications in square brackets</p><p>X<sup>(P)</sup> is used if preventable and non-preventable readmissions were analyzed together. If at least 50% of the readmissions were deemed preventable, a X<sup>(P)</sup> is charted for the respective risk factor</p></table-wrap-foot></table-wrap></p><p id="Par42">In summary, the most prevalent factors associated with preventable MRRs are <italic toggle="yes">prescribing problems</italic>, (most often <italic toggle="yes">underprescribing</italic>), <italic toggle="yes">adherence issues</italic>, <italic toggle="yes">insufficient ambulatory monitoring</italic>, and <italic toggle="yes">transfer of care-errors</italic>, e.g., incomplete medication discharge information. The drug group most often associated with preventable MRRs is <italic toggle="yes">antithrombotic agents</italic>.</p></sec></sec><sec id="Sec16"><title>Discussion</title><p id="Par43">To our knowledge, this is the first review to assess 30-day MRRs in adult patients in general internal medicine. We grouped our findings into five categories: <italic toggle="yes">patient characteristics</italic>, <italic toggle="yes">medication groups</italic>, <italic toggle="yes">MRPs</italic>, <italic toggle="yes">ADRs</italic>, and <italic toggle="yes">readmission diagnoses</italic>. These categories reflect the heterogeneity of the included studies. Several articles report MRPs, including ADRs, suggesting that the researchers were specifically checking whether the associated readmissions were caused by MRPs. Others describe or validate readmission risk prediction models. Where these models identify risk factors associated with medications, we have included those factors in our analysis. Much of a risk prediction model&#8217;s development is based on the idea that predictive factors&#8212;e.g., <italic toggle="yes">number of medications</italic> or the prescription of certain <italic toggle="yes">medication groups</italic>&#8212;must be entered in electronic medical records in a standardized way [<xref ref-type="bibr" rid="CR67">67</xref>]. Furthermore, our analysis entails studies that examined all-cause readmissions. In those cases, we also extracted medication-related factors. Additionally, the diversity of the categories reflects readmissions&#8217; tendency to be multifactorial and complex.</p><p id="Par44">Patient characteristics contributing to MRRs were <italic toggle="yes">older age</italic> (most often&#8201;&#8805;&#8201;65 years), <italic toggle="yes">polypharmacy</italic>, <italic toggle="yes">number of medication changes at initial hospital stay</italic>, <italic toggle="yes">being prescribed PIMs</italic>, having <italic toggle="yes">a higher MRCI</italic>, and <italic toggle="yes">being help-dependent in the home environment</italic>. The medication groups most often associated with MRRs were <italic toggle="yes">antithrombotics</italic>, <italic toggle="yes">opioid analgesics</italic>, <italic toggle="yes">insulin</italic>, and <italic toggle="yes">diuretics</italic>. The most common diagnoses for MRRs were <italic toggle="yes">bleeding</italic>, <italic toggle="yes">constipation</italic>, <italic toggle="yes">hypoglycemia</italic>, and <italic toggle="yes">hypotension</italic>. These can be connected to the identified medication groups. As an example, as antithrombotic agents reduce the formation of thrombi, they can also lead to bleeding. And as opioids commonly induce constipation, laxatives should be prescribed along with them [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. In the case of insulin, an injection at too high a dose, e.g., due to non-adherence with mealtimes or prescription errors, this may result in severe hypoglycemia, often requiring hospitalization. Lastly, especially in older adults with restricted sodium intake, diuretics can lead to volume depletion, leading to hypotension.</p><p id="Par45">Although ADRs were often mentioned, MEs were also found. These include adherence problems and prescribing problems, with underprescribing found to be the most prevalent regarding MRRs. Misprescribing and overprescribing also caused MRRs in the analyzed studies. Another risk factor was suboptimal transition from an acute care setting to an ambulatory one. Compared to MEs, ADR rates tend to be higher in the literature. However, measurement bias may amplify ADRs&#8217; prevalence, i.e., because ADRs are easier to detect and are recorded in a more standardized manner, they are more likely both to be detected and to be recorded recognizably. In many countries, including the USA, where most of the included studies originate, diagnoses are recorded using the International Classification of Diseases (ICD) codes. As ADRs can be reported by ICD codes, they are relatively readily extracted from electronic health records for retrospective studies [<xref ref-type="bibr" rid="CR70">70</xref>&#8211;<xref ref-type="bibr" rid="CR74">74</xref>]. MEs are not captured in this standardized manner, and their endpoints often lead medical professionals to mistake them for ADRs. For example, a prescription error that leads to an opioid analgesic overdose also becomes an ADR. Therefore, when taking measures to reduce MRRs, the promotion of medication adherence, education and monitoring, and the improvement of transition-of-care processes are all important. The identified risk factors can be used by clinicians to prioritize patients for measures to reduce MRRs. These could include a combination of medication reviews, medication reconciliation, education, and interprofessional transition-of-care programs, as a meta-analysis has proven them effective at reducing readmissions [<xref ref-type="bibr" rid="CR75">75</xref>].</p><p id="Par46">Additionally, we summarized risk factors for preventable MRRs. Considering the preventability definitions' and study designs' high levels of heterogeneity, these results should be interpreted with caution. As expected, the results indicate that, when MRPs such as prescribing problems, adherence issues, and transfer-of-care errors were assessed, they were almost always deemed preventable. Some studies also found ADRs preventable, e.g., an allergic drug reaction in a patient known to be allergic to that drug&#8212;which could also qualify as a preventable ME (misprescribing). The drug groups most often associated with preventable MRRs were <italic toggle="yes">antithrombotics</italic>, <italic toggle="yes">antihypertensives</italic>, <italic toggle="yes">analgesics</italic>, especially <italic toggle="yes">opioids</italic>, and <italic toggle="yes">antibacterial agents</italic>. This is partly reflected in the readmission diagnoses, of which <italic toggle="yes">arrhythmia</italic> (often an indication for antithrombotics in case of atrial fibrillation), <italic toggle="yes">heart failure</italic> (indication for antihypertensives, other cardiovascular drugs), and <italic toggle="yes">infection</italic> (indication for antibacterial agents) were most often associated with preventable MRRs. Therefore, patients receiving the respective drug groups or diagnoses could be prioritized for interventions to avoid readmissions.</p><p id="Par47">Our findings align with those of two reviews that dealt with MRRs, but with slightly different primary objectives [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Both reviews mentioned the Charlson Comorbidity Index [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. A higher comorbidity index is associated with polypharmacy and higher MRCIs [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]&#8212;both of which are identified in our results as risk factors. Both studies noted links between specific drug groups with MRRs [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], all of which are included in our results. Linkens et al. [<xref ref-type="bibr" rid="CR16">16</xref>] also correlated adherence problems, transition of care issues, falls, and weight loss with MRRs. Our findings are similar but more detailed, mainly because our primary objectives focused specifically on risk factors for MRRs.</p><p id="Par48">While our study sample provides reasonably detailed findings on physical contributors to rehospitalizations, social determinants of health (SDH) are, in our opinion, underrepresented not only here but throughout the literature. These include nutritional status [<xref ref-type="bibr" rid="CR78">78</xref>], living arrangements [<xref ref-type="bibr" rid="CR79">79</xref>&#8211;<xref ref-type="bibr" rid="CR81">81</xref>], and discharge against medical advice [<xref ref-type="bibr" rid="CR81">81</xref>], all of which correlate well with all-cause readmissions. Living in a nursing home [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] or a poor neighborhood [<xref ref-type="bibr" rid="CR81">81</xref>], or depending entirely on a state pension [<xref ref-type="bibr" rid="CR81">81</xref>] are also associated with a higher readmission risk. Another cause for concern is a lower level of social support: unmarried, widowed, or homeless patients are more likely to be readmitted [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par49">The LACE index [<xref ref-type="bibr" rid="CR82">82</xref>] and the HOSPITAL score [<xref ref-type="bibr" rid="CR83">83</xref>] are prediction models for all-cause readmissions. The LACE index looks at length of stay (L), acuity of admission (A), comorbidity (C), and emergency department use in&#160;the previous 6 months (E); and the HOSPITAL score focuses on low hemoglobin level at discharge (H), discharge following oncological treatment (O), low sodium level (S), procedures received during hospital stay (any ICD-9 coded procedures) (P), index admission data: urgent/emergency (non-elective) (IT), number of admissions over the previous year (A), and length of stay&#8201;&#8805;&#8201;5 days (L) [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>].</p><p id="Par50">Adding SDHs to the LACE index improved its predictivity [<xref ref-type="bibr" rid="CR84">84</xref>]. However, adding them to the HOSPITAL score yielded conflicting results: in one study, the HOSPITAL c-statistic improved [<xref ref-type="bibr" rid="CR85">85</xref>]; in another it did not change significantly [<xref ref-type="bibr" rid="CR86">86</xref>]. This could be because the HOSPITAL score's contributing risk factors already reflect the effects of SDHs [<xref ref-type="bibr" rid="CR86">86</xref>]. A subgroup analysis showed improved predictive power in older patients [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par51">Ultimately, as few of our included studies report on SDHs, their roles, if any, remain unclear. However, we hypothesize that they contribute importantly to MRRs.</p><p id="Par52">For example, the clear link between SDHs and medication adherence [<xref ref-type="bibr" rid="CR87">87</xref>&#8211;<xref ref-type="bibr" rid="CR90">90</xref>], a critical risk factor for MRRs, is congruent with our hypothesis. We strongly suspect that SDHs are underrepresented in our findings, not because they are less important than other demographic risk factors, but because data relating to them are not readily available in electronic health records. Therefore, we suggest more detailed research to investigate SDHs&#8217; influence on MRRs.</p><p id="Par53">This scoping review has several limitations: Most notably, as we did not assess the risk of bias in the included studies, we may have included substandard research. We tried to minimize this limitation by excluding articles published without peer-review. Conversely, it is possible that excluding &#8220;grey&#8221; literature&#8212;a conscious publication bias&#8212;also limited the quality of our results. To mitigate the risk of omissions, we performed backward citation searches. And to optimize database record queries&#8217; specificity, we added terms to our search strings representing risk factors or medication groups. One conceivable result would be that studies only mentioning very specific associations, e.g., between <italic toggle="yes">polypharmacy</italic> and <italic toggle="yes">readmission,</italic> would have been left out. Still, considering that the studies included through citation searches had no significant effects on the results, we are confident that, for the purposes of this scoping review, we identified the most pertinent risk factors. In other words, our findings regarding risk factors provide a useful starting point to prioritize patients for MRR reduction measures.</p></sec><sec id="Sec17"><title>Conclusions</title><p id="Par54">This scoping review summarizes potentially MRR&#8211;indicative data identified in 50 included studies. These can be categorized as <italic toggle="yes">patient characteristics</italic>, <italic toggle="yes">medication groups</italic>, <italic toggle="yes">MRPs and ADRs</italic>, and <italic toggle="yes">readmission diagnoses</italic>. Our analyses indicate that patients who have polypharmacy and are help-dependent, prescribed PIMs, older (most often mentioned threshold&#8201;&#8805;&#8201;65 years), and/or received medication changes during their initial hospitalization are at higher risk of experiencing MRRs. Given the prevalence of these risk factors among frail older adults, our findings highlight the importance of targeted interventions, such as medication reviews and deprescribing unnecessary medications, for this vulnerable population. Numerous medication groups appear to be associated with MRRs, most commonly <italic toggle="yes">antithrombotic agents</italic>, <italic toggle="yes">opioid analgesics</italic>, <italic toggle="yes">insulin</italic>, and <italic toggle="yes">diuretics</italic>. The leading MRPs resulting in MRRs are <italic toggle="yes">non-adherence</italic>, <italic toggle="yes">prescribing problems</italic>, and <italic toggle="yes">suboptimal transition of care</italic>. As all of these are MEs, all are also potentially preventable. In health care settings with limited resources, these risk factors can serve as risk indicators, allowing care teams to prioritize particularly vulnerable patients for interventions aimed at reducing preventable MRRs. And finally, one question that warrants consideration is that of whether certain social factors such living situations are predictive of some types of MRPs.</p></sec><sec sec-type="supplementary-material"><sec id="Sec18"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12913_2023_10028_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p><bold>Additional file 1.</bold>&#160;</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12913_2023_10028_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p><bold>Additional file 2.</bold></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12913_2023_10028_MOESM3_ESM.xlsx" position="float" orientation="portrait"><caption><p><bold>Additional file 3.</bold></p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADR</term><def><p id="Par5">Adverse drug reaction</p></def></def-item><def-item><term>ATC</term><def><p id="Par6">Anatomical Therapeutic Chemical</p></def></def-item><def-item><term>ICD</term><def><p id="Par7">International Classification of Diseases</p></def></def-item><def-item><term>MEs</term><def><p id="Par8">Medication errors</p></def></def-item><def-item><term>MRCI</term><def><p id="Par9">Medication regimen complexity index</p></def></def-item><def-item><term>MRP</term><def><p id="Par10">Medication-related problem</p></def></def-item><def-item><term>MRR</term><def><p id="Par11">Medication-related readmission</p></def></def-item><def-item><term>PIM</term><def><p id="Par12">Potentially inappropriate medication</p></def></def-item><def-item><term>SDH</term><def><p id="Par13">Social determinants of health</p></def></def-item><def-item><term>SHs</term><def><p id="Par14">Subject headings</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to express their heartfelt gratitude to Dr. Marc von Gernler, medical librarian, for his help in establishing and improving our search strategy and Chris Shultis, medical editor, for editing this article.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>NS developed the search strategy as well as the eligibility criteria and performed the database searches, which were verified by CM. All records were screened by NS and CM. Potentially relevant full-texts articles were read by NS and CM, who then discussed any discrepancies. NS charted the data, then discussed and resolved uncertainties with CM. NS analyzed and interpreted the data and drafted the initial manuscript, while CM reviewed and revised the drafts. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The authors have not received specific funding for this scoping review.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated for or analyzed in this study is published in this article and its supplementary information.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par55">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par56">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par57">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smeraglio</surname><given-names>A</given-names></name><name name-style="western"><surname>Heidenreich</surname><given-names>PA</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>G</given-names></name><name name-style="western"><surname>Hopkins</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Shieh</surname><given-names>L</given-names></name></person-group><article-title>Patient vs provider perspectives of 30-day hospital readmissions</article-title><source>BMJ Open Qual</source><year>2019</year><volume>8</volume><issue>1</issue><fpage>e000264</fpage><pub-id pub-id-type="pmid">30687798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjoq-2017-000264</pub-id><pub-id pub-id-type="pmcid">PMC6327873</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jencks</surname><given-names>SF</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MV</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>EA</given-names></name></person-group><article-title>Rehospitalizations among patients in the medicare fee-for-service program</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><issue>14</issue><fpage>1418</fpage><lpage>1428</lpage><pub-id pub-id-type="pmid">19339721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMsa0803563</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Caballos</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramos-Diaz</surname><given-names>F</given-names></name><name name-style="western"><surname>Jim&#233;nez-Mole&#243;n</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Bueno-Cavanillas</surname><given-names>A</given-names></name></person-group><article-title>Drug-related problems in older people after hospital discharge and interventions to reduce them</article-title><source>Age Ageing</source><year>2010</year><volume>39</volume><issue>4</issue><fpage>430</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">20497947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ageing/afq045</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer-Massetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Hofstetter</surname><given-names>V</given-names></name><name name-style="western"><surname>Hedinger-Grogg</surname><given-names>B</given-names></name><name name-style="western"><surname>Meier</surname><given-names>CR</given-names></name><name name-style="western"><surname>Guglielmo</surname><given-names>BJ</given-names></name></person-group><article-title>Medication-related problems during transfer from hospital to home care: baseline data from Switzerland</article-title><source>Int J Clin Pharm</source><year>2018</year><volume>40</volume><issue>6</issue><fpage>1614</fpage><lpage>1620</lpage><pub-id pub-id-type="pmid">30291577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11096-018-0728-3</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parekh</surname><given-names>N</given-names></name><name name-style="western"><surname>Ali</surname><given-names>K</given-names></name><name name-style="western"><surname>Page</surname><given-names>A</given-names></name><name name-style="western"><surname>Roper</surname><given-names>T</given-names></name><name name-style="western"><surname>Rajkumar</surname><given-names>C</given-names></name></person-group><article-title>Incidence of medication-related harm in older adults after hospital discharge: A systematic review</article-title><source>J Am Geriatr Soc</source><year>2018</year><volume>66</volume><issue>9</issue><fpage>1812</fpage><lpage>1822</lpage><pub-id pub-id-type="pmid">29972591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.15419</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">The definition of drug-related problems [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.pcne.org/sig/drp/drug-related-problems.php">http://www.pcne.org/sig/drp/drug-related-problems.php</ext-link>].</mixed-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strand</surname><given-names>LM</given-names></name><name name-style="western"><surname>Morley</surname><given-names>PC</given-names></name><name name-style="western"><surname>Cipolle</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>R</given-names></name><name name-style="western"><surname>Lamsam</surname><given-names>GD</given-names></name></person-group><article-title>Drug-related problems: their structure and function</article-title><source>DICP</source><year>1990</year><volume>24</volume><issue>11</issue><fpage>1093</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">2275235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/106002809002401114</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vest</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gamm</surname><given-names>LD</given-names></name><name name-style="western"><surname>Oxford</surname><given-names>BA</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>MI</given-names></name><name name-style="western"><surname>Slawson</surname><given-names>KM</given-names></name></person-group><article-title>Determinants of preventable readmissions in the United States: a systematic review</article-title><source>Implement Sci</source><year>2010</year><volume>5</volume><issue>1</issue><fpage>88</fpage><pub-id pub-id-type="pmid">21083908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1748-5908-5-88</pub-id><pub-id pub-id-type="pmcid">PMC2996340</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Hospital Readmissions Reduction Program (HRRP) [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program">www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program</ext-link>].</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Morabet</surname><given-names>N</given-names></name><name name-style="western"><surname>Uitvlugt</surname><given-names>EB</given-names></name><name name-style="western"><surname>van den Bemt</surname><given-names>BJF</given-names></name><name name-style="western"><surname>van den Bemt</surname><given-names>PMLA</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>MJA</given-names></name><name name-style="western"><surname>Karapinar-Carkit</surname><given-names>F</given-names></name></person-group><article-title>Prevalence and preventability of drug-related hospital readmissions: A systematic review</article-title><source>J Am Geriatr Soc</source><year>2018</year><volume>66</volume><issue>3</issue><fpage>602</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">29468640</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.15244</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banholzer</surname><given-names>S</given-names></name><name name-style="western"><surname>Dunkelmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Haschke</surname><given-names>M</given-names></name><name name-style="western"><surname>Derungs</surname><given-names>A</given-names></name><name name-style="western"><surname>Exadaktylos</surname><given-names>A</given-names></name><name name-style="western"><surname>Krahenbuhl</surname><given-names>S</given-names></name><name name-style="western"><surname>Liakoni</surname><given-names>E</given-names></name></person-group><article-title>Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission</article-title><source>Swiss Med Wkly</source><year>2021</year><volume>151</volume><fpage>w20400</fpage><pub-id pub-id-type="pmid">33516159</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4414/smw.2021.20400</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalleur</surname><given-names>O</given-names></name><name name-style="western"><surname>Beeler</surname><given-names>PE</given-names></name><name name-style="western"><surname>Schnipper</surname><given-names>JL</given-names></name><name name-style="western"><surname>Donze</surname><given-names>J</given-names></name></person-group><article-title>30-day potentially avoidable readmissions due to adverse drug events</article-title><source>J Patient Saf</source><year>2021</year><volume>17</volume><issue>5</issue><fpage>e379</fpage><lpage>e386</lpage><pub-id pub-id-type="pmid">28306610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PTS.0000000000000346</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glans</surname><given-names>M</given-names></name><name name-style="western"><surname>Kragh Ekstam</surname><given-names>A</given-names></name><name name-style="western"><surname>Jakobsson</surname><given-names>U</given-names></name><name name-style="western"><surname>Bondesson</surname><given-names>A</given-names></name><name name-style="western"><surname>Midlov</surname><given-names>P</given-names></name></person-group><article-title>Medication-related hospital readmissions within 30 days of discharge-A retrospective study of risk factors in older adults</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><issue>6</issue><fpage>e0253024</fpage><pub-id pub-id-type="pmid">34111185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0253024</pub-id><pub-id pub-id-type="pmcid">PMC8191889</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uitvlugt</surname><given-names>EB</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>MJA</given-names></name><name name-style="western"><surname>Siegert</surname><given-names>CEH</given-names></name><name name-style="western"><surname>Kneepkens</surname><given-names>EL</given-names></name><name name-style="western"><surname>van den Bemt</surname><given-names>BJF</given-names></name><name name-style="western"><surname>van den Bemt</surname><given-names>PMLA</given-names></name><name name-style="western"><surname>Karapinar-Carkit</surname><given-names>F</given-names></name></person-group><article-title>Medication-related hospital readmissions within 30 days of discharge: prevalence, preventability, type of medication errors and risk factors</article-title><source>Front Pharmacol</source><year>2021</year><volume>12</volume><fpage>567424</fpage><pub-id pub-id-type="pmid">33927612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2021.567424</pub-id><pub-id pub-id-type="pmcid">PMC8077030</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitaker</surname><given-names>AS</given-names></name><name name-style="western"><surname>Cottrell</surname><given-names>WN</given-names></name></person-group><article-title>What proportion of unplanned re-presentations to an emergency department are medication related and preventable?</article-title><source>J Pharm Pract Res</source><year>2019</year><volume>49</volume><issue>6</issue><fpage>546</fpage><lpage>556</lpage></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Linkens AEMJH, Milosevic V, van der Kuy PHM, Damen-Hendriks VH, Mestres Gonzalvo C, Hurkens KPGM: Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm 2020;42(5):1243&#8211;1251.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11096-020-01040-1</pub-id><pub-id pub-id-type="pmcid">PMC7522062</pub-id><pub-id pub-id-type="pmid">32472324</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arksey</surname><given-names>H</given-names></name><name name-style="western"><surname>O'Malley</surname><given-names>L</given-names></name></person-group><article-title>Scoping studies: towards a methodological framework</article-title><source>Int J Soc Res Methodol</source><year>2005</year><volume>8</volume><issue>1</issue><fpage>19</fpage><lpage>32</lpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name><name name-style="western"><surname>Marnie</surname><given-names>C</given-names></name><name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>D</given-names></name><name name-style="western"><surname>Munn</surname><given-names>Z</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>L</given-names></name><name name-style="western"><surname>McInerney</surname><given-names>P</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>CM</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>H</given-names></name></person-group><article-title>Updated methodological guidance for the conduct of scoping reviews</article-title><source>JBI Evid Synth</source><year>2020</year><volume>18</volume><issue>10</issue><fpage>2119</fpage><lpage>2126</lpage><pub-id pub-id-type="pmid">33038124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.11124/JBIES-20-00167</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>E</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>W</given-names></name><name name-style="western"><surname>O'Brien</surname><given-names>KK</given-names></name><name name-style="western"><surname>Colquhoun</surname><given-names>H</given-names></name><name name-style="western"><surname>Levac</surname><given-names>D</given-names></name><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name><name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name><name name-style="western"><surname>Horsley</surname><given-names>T</given-names></name><name name-style="western"><surname>Weeks</surname><given-names>L</given-names></name><etal/></person-group><article-title>PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation</article-title><source>Ann Intern Med</source><year>2018</year><volume>169</volume><issue>7</issue><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">30178033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M18-0850</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naranjo</surname><given-names>CA</given-names></name><name name-style="western"><surname>Busto</surname><given-names>U</given-names></name><name name-style="western"><surname>Sellers</surname><given-names>EM</given-names></name><name name-style="western"><surname>Sandor</surname><given-names>P</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>I</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>EA</given-names></name><name name-style="western"><surname>Janecek</surname><given-names>E</given-names></name><name name-style="western"><surname>Domecq</surname><given-names>C</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>DJ</given-names></name></person-group><article-title>A method for estimating the probability of adverse drug reactions</article-title><source>Clin Pharmacol Ther</source><year>1981</year><volume>30</volume><issue>2</issue><fpage>239</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">7249508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/clpt.1981.154</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kempen</surname><given-names>TGH</given-names></name><name name-style="western"><surname>Hedstr&#246;m</surname><given-names>M</given-names></name><name name-style="western"><surname>Olsson</surname><given-names>H</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>A</given-names></name><name name-style="western"><surname>Ottosson</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Sammak</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gillespie</surname><given-names>U</given-names></name></person-group><article-title>Assessment tool for hospital admissions related to medications: development and validation in older patients</article-title><source>Int J Clin Pharm</source><year>2019</year><volume>41</volume><issue>1</issue><fpage>198</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">30585296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11096-018-0768-8</pub-id><pub-id pub-id-type="pmcid">PMC6394508</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>JB</given-names></name><name name-style="western"><surname>Jeter</surname><given-names>E</given-names></name><name name-style="western"><surname>Sessoms</surname><given-names>CJ</given-names></name></person-group><article-title>Rates and types of medication-related problems in patients rehospitalized within 30 days of discharge from a community hospital</article-title><source>J Pharm Technol</source><year>2020</year><volume>36</volume><issue>2</issue><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">34752555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/8755122519883642</pub-id><pub-id pub-id-type="pmcid">PMC7047247</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dreyer</surname><given-names>R</given-names></name><name name-style="western"><surname>Viljoen</surname><given-names>AJ</given-names></name></person-group><article-title>Evaluation of factors and patterns influencing the 30-day readmission rate at a tertiary-level hospital in a resource-constrained setting in Cape Town</article-title><source>South Africa S Afr Med J</source><year>2019</year><volume>109</volume><issue>3</issue><fpage>164</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">30834872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7196/SAMJ.2019.v109i3.13367</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yam</surname><given-names>CH</given-names></name><name name-style="western"><surname>Wong</surname><given-names>EL</given-names></name><name name-style="western"><surname>Chan</surname><given-names>FW</given-names></name><name name-style="western"><surname>Leung</surname><given-names>MC</given-names></name><name name-style="western"><surname>Wong</surname><given-names>FY</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>AW</given-names></name><name name-style="western"><surname>Yeoh</surname><given-names>EK</given-names></name></person-group><article-title>Avoidable readmission in Hong Kong&#8211;system, clinician, patient or social factor?</article-title><source>BMC Health Serv Res</source><year>2010</year><volume>10</volume><fpage>311</fpage><pub-id pub-id-type="pmid">21080970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1472-6963-10-311</pub-id><pub-id pub-id-type="pmcid">PMC2993701</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frankl</surname><given-names>SE</given-names></name><name name-style="western"><surname>Breeling</surname><given-names>JL</given-names></name><name name-style="western"><surname>Goldman</surname><given-names>L</given-names></name></person-group><article-title>Preventability of emergent hospital readmission</article-title><source>Am J Med</source><year>1991</year><volume>90</volume><issue>6</issue><fpage>667</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">2042681</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toh</surname><given-names>MR</given-names></name><name name-style="western"><surname>Teo</surname><given-names>V</given-names></name><name name-style="western"><surname>Kwan</surname><given-names>YH</given-names></name><name name-style="western"><surname>Raaj</surname><given-names>S</given-names></name><name name-style="western"><surname>Tan</surname><given-names>SY</given-names></name><name name-style="western"><surname>Tan</surname><given-names>JZ</given-names></name></person-group><article-title>Association between number of doses per day, number of medications and patient's non-compliance, and frequency of readmissions in a multi-ethnic Asian population</article-title><source>Prev Med Rep</source><year>2014</year><volume>1</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">26844038</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pmedr.2014.10.001</pub-id><pub-id pub-id-type="pmcid">PMC4721491</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willson</surname><given-names>MN</given-names></name><name name-style="western"><surname>Greer</surname><given-names>CL</given-names></name><name name-style="western"><surname>Weeks</surname><given-names>DL</given-names></name></person-group><article-title>Medication regimen complexity and hospital readmission for an adverse drug event</article-title><source>Ann Pharmacother</source><year>2014</year><volume>48</volume><issue>1</issue><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">24259639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1060028013510898</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Nikolaus T, Specht-Leible N, Kruse W, Oster P, Schlierf G: [The early rehospitalization of elderly patients. Causes and prevention]. Dtsch Med Wochenschr 1992;117(11):403&#8211;407.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-2008-1062325</pub-id><pub-id pub-id-type="pmid">1544342</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ekerstad</surname><given-names>N</given-names></name><name name-style="western"><surname>Bylin</surname><given-names>K</given-names></name><name name-style="western"><surname>Karlson</surname><given-names>BW</given-names></name></person-group><article-title>Early rehospitalizations of frail elderly patients - the role of medications: a clinical, prospective, observational trial</article-title><source>Drug Healthcare Patient Saf</source><year>2017</year><volume>9</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/DHPS.S139237</pub-id><pub-id pub-id-type="pmcid">PMC5571818</pub-id><pub-id pub-id-type="pmid">28860862</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothwell</surname><given-names>M</given-names></name><name name-style="western"><surname>Jukka</surname><given-names>C</given-names></name><name name-style="western"><surname>Lum</surname><given-names>E</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>C</given-names></name><name name-style="western"><surname>Kyriakides</surname><given-names>P</given-names></name></person-group><article-title>Retrospective analysis of emergency readmissions to rural and regional hospitals</article-title><source>J Pharm Pract Res</source><year>2011</year><volume>41</volume><issue>4</issue><fpage>290</fpage><lpage>294</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witherington</surname><given-names>EM</given-names></name><name name-style="western"><surname>Pirzada</surname><given-names>OM</given-names></name><name name-style="western"><surname>Avery</surname><given-names>AJ</given-names></name></person-group><article-title>Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study</article-title><source>Qual Saf Health Care</source><year>2008</year><volume>17</volume><issue>1</issue><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">18245223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/qshc.2006.020842</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weir</surname><given-names>DL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>TC</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>EG</given-names></name><name name-style="western"><surname>Motulsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Abrahamowicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>S</given-names></name><name name-style="western"><surname>Buckeridge</surname><given-names>D</given-names></name><name name-style="western"><surname>Tamblyn</surname><given-names>R</given-names></name></person-group><article-title>Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events</article-title><source>J Am Geriatr Soc</source><year>2020</year><volume>68</volume><issue>6</issue><fpage>1184</fpage><lpage>1192</lpage><pub-id pub-id-type="pmid">32232988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.16413</pub-id><pub-id pub-id-type="pmcid">PMC7687123</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwab</surname><given-names>C</given-names></name><name name-style="western"><surname>Korb-Savoldelli</surname><given-names>V</given-names></name><name name-style="western"><surname>Escudie</surname><given-names>JB</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>C</given-names></name><name name-style="western"><surname>Durieux</surname><given-names>P</given-names></name><name name-style="western"><surname>Saint-Jean</surname><given-names>O</given-names></name><name name-style="western"><surname>Sabatier</surname><given-names>B</given-names></name></person-group><article-title>Iatrogenic risk factors associated with hospital readmission of elderly patients: A matched case-control study using a clinical data warehouse</article-title><source>J Clin Pharm Ther</source><year>2018</year><volume>43</volume><issue>3</issue><fpage>393</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">29446115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jcpt.12670</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnett</surname><given-names>NL</given-names></name><name name-style="western"><surname>Dave</surname><given-names>K</given-names></name><name name-style="western"><surname>Athwal</surname><given-names>D</given-names></name><name name-style="western"><surname>Parmar</surname><given-names>P</given-names></name><name name-style="western"><surname>Kaher</surname><given-names>S</given-names></name><name name-style="western"><surname>Ward</surname><given-names>C</given-names></name></person-group><article-title>Impact of an integrated medicines management service on preventable medicines-related readmission to hospital: a descriptive study</article-title><source>Eur J Hosp Pharm</source><year>2017</year><volume>24</volume><issue>6</issue><fpage>327</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">31156966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ejhpharm-2016-000984</pub-id><pub-id pub-id-type="pmcid">PMC6451502</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koekkoek</surname><given-names>D</given-names></name><name name-style="western"><surname>Bayley</surname><given-names>KB</given-names></name><name name-style="western"><surname>Brown</surname><given-names>A</given-names></name><name name-style="western"><surname>Rustvold</surname><given-names>DL</given-names></name></person-group><article-title>Hospitalists assess the causes of early hospital readmissions</article-title><source>J Hosp Med</source><year>2011</year><volume>6</volume><issue>7</issue><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">21915999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jhm.909</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balla</surname><given-names>U</given-names></name><name name-style="western"><surname>Malnick</surname><given-names>S</given-names></name><name name-style="western"><surname>Schattner</surname><given-names>A</given-names></name></person-group><article-title>Early readmissions to the department of medicine as a screening tool for monitoring quality of care problems</article-title><source>Medicine (Baltimore)</source><year>2008</year><volume>87</volume><issue>5</issue><fpage>294</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">18794712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0b013e3181886f93</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feigenbaum</surname><given-names>P</given-names></name><name name-style="western"><surname>Neuwirth</surname><given-names>E</given-names></name><name name-style="western"><surname>Trowbridge</surname><given-names>L</given-names></name><name name-style="western"><surname>Teplitsky</surname><given-names>S</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>CA</given-names></name><name name-style="western"><surname>Fireman</surname><given-names>E</given-names></name><name name-style="western"><surname>Dorman</surname><given-names>J</given-names></name><name name-style="western"><surname>Bellows</surname><given-names>J</given-names></name></person-group><article-title>Factors contributing to all-cause 30-day readmissions: a structured case series across 18 hospitals</article-title><source>Med Care</source><year>2012</year><volume>50</volume><issue>7</issue><fpage>599</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">22354212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MLR.0b013e318249ce72</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Classen</surname><given-names>DC</given-names></name><name name-style="western"><surname>Jaser</surname><given-names>L</given-names></name><name name-style="western"><surname>Budnitz</surname><given-names>DS</given-names></name></person-group><article-title>Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance</article-title><source>Jt Comm J Qual Patient Saf</source><year>2010</year><volume>36</volume><issue>1</issue><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">20112660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1553-7250(10)36003-x</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porter</surname><given-names>M</given-names></name><name name-style="western"><surname>Quillen</surname><given-names>D</given-names></name><name name-style="western"><surname>Fe Agana</surname><given-names>D</given-names></name><name name-style="western"><surname>Chacko</surname><given-names>L</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>K</given-names></name><name name-style="western"><surname>Bielick</surname><given-names>L</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Carek</surname><given-names>PJ</given-names></name></person-group><article-title>Are patients frequently readmitted to the hospital different from the other admitted patients?</article-title><source>J Am Board Fam Med</source><year>2019</year><volume>32</volume><issue>1</issue><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">30610142</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3122/jabfm.2019.01.180052</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wetherell</surname><given-names>M</given-names></name><name name-style="western"><surname>Sweeney</surname><given-names>M</given-names></name><name name-style="western"><surname>Weingart</surname><given-names>SN</given-names></name></person-group><article-title>Can clinicians predict readmissions? A prospective cohort study</article-title><source>J Healthc Qual</source><year>2017</year><volume>39</volume><issue>6</issue><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">27631711</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JHQ.0000000000000056</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aljishi</surname><given-names>M</given-names></name><name name-style="western"><surname>Parekh</surname><given-names>K</given-names></name></person-group><article-title>Risk factors for general medicine readmissions and association with mortality</article-title><source>N Z Med J</source><year>2014</year><volume>127</volume><issue>1394</issue><fpage>42</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">24929570</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beckner</surname><given-names>A</given-names></name><name name-style="western"><surname>Liberty</surname><given-names>KR</given-names></name><name name-style="western"><surname>Cohn</surname><given-names>T</given-names></name></person-group><article-title>Medication adherence among home health patients facing hospital readmissions</article-title><source>Medsurg Nurs</source><year>2021</year><volume>30</volume><issue>6</issue><fpage>396</fpage><lpage>402</lpage></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allaudeen</surname><given-names>N</given-names></name><name name-style="western"><surname>Vidyarthi</surname><given-names>A</given-names></name><name name-style="western"><surname>Maselli</surname><given-names>J</given-names></name><name name-style="western"><surname>Auerbach</surname><given-names>A</given-names></name></person-group><article-title>Redefining readmission risk factors for general medicine patients</article-title><source>J Hosp Med</source><year>2011</year><volume>6</volume><issue>2</issue><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">20945293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jhm.805</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>OZ</given-names></name><name name-style="western"><surname>Fridman</surname><given-names>R</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>BT</given-names></name><name name-style="western"><surname>Shane</surname><given-names>R</given-names></name><name name-style="western"><surname>Pevnick</surname><given-names>JM</given-names></name></person-group><article-title>Medication adherence as a predictor of 30-day hospital readmissions</article-title><source>Patient Prefer Adherence</source><year>2017</year><volume>11</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">28461742</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/PPA.S125672</pub-id><pub-id pub-id-type="pmcid">PMC5404806</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Logue</surname><given-names>E</given-names></name><name name-style="western"><surname>Smucker</surname><given-names>W</given-names></name><name name-style="western"><surname>Regan</surname><given-names>C</given-names></name></person-group><article-title>Admission data predict high hospital readmission risk</article-title><source>J Am Board Fam Med</source><year>2016</year><volume>29</volume><issue>1</issue><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">26769877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3122/jabfm.2016.01.150127</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Lau MHM, Tenney JW. Evaluation of drug-disease interactions and their association with unplanned hospital readmission utilizing STOPP version 2 criteria. Geriatrics. 2017;2(4):33.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/geriatrics2040033</pub-id><pub-id pub-id-type="pmcid">PMC6371179</pub-id><pub-id pub-id-type="pmid">31011043</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pavon</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>McConnell</surname><given-names>E</given-names></name><name name-style="western"><surname>Hastings</surname><given-names>SN</given-names></name></person-group><article-title>Identifying risk of readmission in hospitalized elderly adults through inpatient medication exposure</article-title><source>J Am Geriatr Soc</source><year>2014</year><volume>62</volume><issue>6</issue><fpage>1116</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">24802165</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.12829</pub-id><pub-id pub-id-type="pmcid">PMC4157051</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibarra Mira</surname><given-names>ML</given-names></name><name name-style="western"><surname>Caro-Teller</surname><given-names>JM</given-names></name><name name-style="western"><surname>Rodr&#237;guez Quesada</surname><given-names>PP</given-names></name><name name-style="western"><surname>Garcia-Mu&#241;oz</surname><given-names>C</given-names></name><name name-style="western"><surname>A&#241;ino Alba</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferrari Piquero</surname><given-names>JM</given-names></name></person-group><article-title>Impact of a pharmaceutical care program at discharge on patients at high risk of readmission according to the hospital score</article-title><source>J Pharm Technol</source><year>2021</year><volume>37</volume><issue>6</issue><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">34790969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/87551225211047607</pub-id><pub-id pub-id-type="pmcid">PMC8592243</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>F</given-names></name><name name-style="western"><surname>Verloo</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhivko</surname><given-names>T</given-names></name><name name-style="western"><surname>Di Giovanni</surname><given-names>S</given-names></name><name name-style="western"><surname>Meyer-Massetti</surname><given-names>C</given-names></name><name name-style="western"><surname>von Gunten</surname><given-names>A</given-names></name><name name-style="western"><surname>Martins</surname><given-names>MM</given-names></name><name name-style="western"><surname>Wernli</surname><given-names>B</given-names></name></person-group><article-title>Risk of 30-day hospital readmission associated with medical conditions and drug regimens of polymedicated, older inpatients discharged home: a registry-based cohort study</article-title><source>BMJ Open</source><year>2021</year><volume>11</volume><issue>7</issue><fpage>e052755</fpage><pub-id pub-id-type="pmid">34261693</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2021-052755</pub-id><pub-id pub-id-type="pmcid">PMC8281082</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basnet</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Lesser</surname><given-names>M</given-names></name><name name-style="western"><surname>Wolf-Klein</surname><given-names>G</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>G</given-names></name><name name-style="western"><surname>Williams</surname><given-names>M</given-names></name><name name-style="western"><surname>Pekmezaris</surname><given-names>R</given-names></name><name name-style="western"><surname>DiMarzio</surname><given-names>P</given-names></name></person-group><article-title>Thirty-day hospital readmission rate amongst older adults correlates with an increased number of medications, but not with Beers medications</article-title><source>Geriatr Gerontol Int</source><year>2018</year><volume>18</volume><issue>10</issue><fpage>1513</fpage><lpage>1518</lpage><pub-id pub-id-type="pmid">30225904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ggi.13518</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohman</surname><given-names>MC</given-names></name><name name-style="western"><surname>Cotton</surname><given-names>BP</given-names></name><name name-style="western"><surname>Zagaria</surname><given-names>AB</given-names></name><name name-style="western"><surname>Bao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>RL</given-names></name><name name-style="western"><surname>Fortuna</surname><given-names>KL</given-names></name><name name-style="western"><surname>Bruce</surname><given-names>ML</given-names></name></person-group><article-title>Hospitalization risk and potentially inappropriate medications among medicare home health nursing patients</article-title><source>J Gen Intern Med</source><year>2017</year><volume>32</volume><issue>12</issue><fpage>1301</fpage><lpage>1308</lpage><pub-id pub-id-type="pmid">28849426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-017-4157-0</pub-id><pub-id pub-id-type="pmcid">PMC5698223</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schoonover</surname><given-names>H</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>CF</given-names></name><name name-style="western"><surname>Weeks</surname><given-names>DL</given-names></name><name name-style="western"><surname>Willson</surname><given-names>MN</given-names></name><name name-style="western"><surname>Setter</surname><given-names>SM</given-names></name></person-group><article-title>Predicting potential postdischarge adverse drug events and 30-day unplanned hospital readmissions from medication regimen complexity</article-title><source>J Patient Saf</source><year>2014</year><volume>10</volume><issue>4</issue><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">25408236</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PTS.0000000000000067</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>RE</given-names></name><name name-style="western"><surname>Birge</surname><given-names>SJ</given-names></name></person-group><article-title>Cognitive dysfunction, medication management, and the risk of readmission in hospital inpatients</article-title><source>J Am Geriatr Soc</source><year>2016</year><volume>64</volume><issue>7</issue><fpage>1464</fpage><lpage>1468</lpage><pub-id pub-id-type="pmid">27305636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.14200</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanc</surname><given-names>AL</given-names></name><name name-style="western"><surname>Fumeaux</surname><given-names>T</given-names></name><name name-style="western"><surname>Stirnemann</surname><given-names>J</given-names></name><name name-style="western"><surname>Dupuis Lozeron</surname><given-names>E</given-names></name><name name-style="western"><surname>Ourhamoune</surname><given-names>A</given-names></name><name name-style="western"><surname>Desmeules</surname><given-names>J</given-names></name><name name-style="western"><surname>Chopard</surname><given-names>P</given-names></name><name name-style="western"><surname>Perrier</surname><given-names>A</given-names></name><name name-style="western"><surname>Schaad</surname><given-names>N</given-names></name><name name-style="western"><surname>Bonnabry</surname><given-names>P</given-names></name></person-group><article-title>Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><issue>7</issue><fpage>e0219348</fpage><pub-id pub-id-type="pmid">31306461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0219348</pub-id><pub-id pub-id-type="pmcid">PMC6629067</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McAuliffe</surname><given-names>LH</given-names></name><name name-style="western"><surname>Zullo</surname><given-names>AR</given-names></name><name name-style="western"><surname>Dapaah-Afriyie</surname><given-names>R</given-names></name><name name-style="western"><surname>Berard-Collins</surname><given-names>C</given-names></name></person-group><article-title>Development and validation of a transitions-of-care pharmacist tool to predict potentially avoidable 30-day readmissions</article-title><source>Am J Health Syst Pharm</source><year>2018</year><volume>75</volume><issue>3</issue><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">29371191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2146/ajhp170184</pub-id><pub-id pub-id-type="pmcid">PMC9015819</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorensen</surname><given-names>A</given-names></name><name name-style="western"><surname>Grotts</surname><given-names>JF</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>CH</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>G</given-names></name><name name-style="western"><surname>Maranon</surname><given-names>R</given-names></name><name name-style="western"><surname>Whitmire</surname><given-names>N</given-names></name><name name-style="western"><surname>Viramontes</surname><given-names>O</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>S</given-names></name><name name-style="western"><surname>Sefilyan</surname><given-names>E</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>JW</given-names></name><etal/></person-group><article-title>A collaboration among primary care-based clinical pharmacists and community-based health coaches</article-title><source>J Am Geriatr Soc</source><year>2021</year><volume>69</volume><issue>1</issue><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">33026662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.16839</pub-id><pub-id pub-id-type="pmcid">PMC8006864</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fung</surname><given-names>L</given-names></name><name name-style="western"><surname>Huynh</surname><given-names>T</given-names></name><name name-style="western"><surname>Brush</surname><given-names>T</given-names></name><name name-style="western"><surname>Medders</surname><given-names>K</given-names></name><name name-style="western"><surname>El-Kareh</surname><given-names>R</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>CE</given-names></name></person-group><article-title>A correlation of a medication-focused risk score to medication errors at discharge</article-title><source>J Clin Pharmacol</source><year>2020</year><volume>60</volume><issue>11</issue><fpage>1416</fpage><lpage>1423</lpage><pub-id pub-id-type="pmid">32533584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcph.1642</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trautwein</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>S</given-names></name><name name-style="western"><surname>Price</surname><given-names>LL</given-names></name><name name-style="western"><surname>Pavoll</surname><given-names>A</given-names></name><name name-style="western"><surname>Sistla</surname><given-names>P</given-names></name><name name-style="western"><surname>Allison</surname><given-names>GM</given-names></name><name name-style="western"><surname>Leary</surname><given-names>JC</given-names></name><name name-style="western"><surname>Weingart</surname><given-names>SN</given-names></name><name name-style="western"><surname>Freund</surname><given-names>KM</given-names></name></person-group><article-title>Developing a real-time prediction model for medicine service 30-day readmissions</article-title><source>Journal of Clinical Outcomes Management</source><year>2020</year><volume>27</volume><issue>1</issue><fpage>33</fpage><lpage>40</lpage></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Criddle DT, Devine B, Murray K, Budgeon CA, Sanfilippo FM, Gupta S, Davidson A, Etherton-Beer C, Clifford R. Developing PHarmacie-R: A bedside risk prediction tool with a medicines management focus to identify risk of hospital readmission.&#160;Res Social Adm Pharm. 2022;18(7):3137&#8211;48.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sapharm.2021.08.014</pub-id><pub-id pub-id-type="pmid">34556434</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Picker</surname><given-names>D</given-names></name><name name-style="western"><surname>Heard</surname><given-names>K</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>TC</given-names></name><name name-style="western"><surname>Martin</surname><given-names>NR</given-names></name><name name-style="western"><surname>LaRossa</surname><given-names>GN</given-names></name><name name-style="western"><surname>Kollef</surname><given-names>MH</given-names></name></person-group><article-title>The number of discharge medications predicts thirty-day hospital readmission: a cohort study</article-title><source>BMC Health Serv Res</source><year>2015</year><volume>15</volume><fpage>282</fpage><pub-id pub-id-type="pmid">26202163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-015-0950-9</pub-id><pub-id pub-id-type="pmcid">PMC4512093</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>HL</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>KS</given-names></name><name name-style="western"><surname>Manz</surname><given-names>B</given-names></name><name name-style="western"><surname>Nethi</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>V</given-names></name><name name-style="western"><surname>Sundaram</surname><given-names>V</given-names></name><name name-style="western"><surname>Julka</surname><given-names>M</given-names></name></person-group><article-title>Real-time risk tool for pharmacy interventions</article-title><source>Hosp Pharm</source><year>2022</year><volume>57</volume><issue>1</issue><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">35521024</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0018578720973884</pub-id><pub-id pub-id-type="pmcid">PMC9065517</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorajoo</surname><given-names>SR</given-names></name><name name-style="western"><surname>See</surname><given-names>V</given-names></name><name name-style="western"><surname>Chan</surname><given-names>CT</given-names></name><name name-style="western"><surname>Tan</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Tan</surname><given-names>DS</given-names></name><name name-style="western"><surname>Abdul Razak</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ong</surname><given-names>TT</given-names></name><name name-style="western"><surname>Koomanan</surname><given-names>N</given-names></name><name name-style="western"><surname>Yap</surname><given-names>CW</given-names></name><name name-style="western"><surname>Chan</surname><given-names>A</given-names></name></person-group><article-title>Identifying potentially avoidable readmissions: A medication-based 15-day readmission risk stratification algorithm</article-title><source>Pharmacotherapy</source><year>2017</year><volume>37</volume><issue>3</issue><fpage>268</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">28052412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/phar.1896</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">SanFilippo S, Michaud V, Wei J, Bikmetov R, Turgeon J, Brunetti L. Classification and assessment of medication risk in the elderly (CARE): use of a medication risk score to inform patients' readmission likelihood after hospital discharge. J Clin Med. 2021;10(17):3947.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm10173947</pub-id><pub-id pub-id-type="pmcid">PMC8432217</pub-id><pub-id pub-id-type="pmid">34501391</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leffler</surname><given-names>ME</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>DP</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>S</given-names></name><name name-style="western"><surname>Dean</surname><given-names>LS</given-names></name></person-group><article-title>Medication-related readmission risk assessment in older adult patients</article-title><source>J Am College Clin Pharm</source><year>2019</year><volume>2</volume><issue>6</issue><fpage>652</fpage><lpage>659</lpage></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sieck</surname><given-names>C</given-names></name><name name-style="western"><surname>Adams</surname><given-names>W</given-names></name><name name-style="western"><surname>Burkhart</surname><given-names>L</given-names></name></person-group><article-title>Validation of the BOOST Risk Stratification Tool as a Predictor of Unplanned 30-Day Readmission in Elderly Patients</article-title><source>Qual Manag Health Care</source><year>2019</year><volume>28</volume><issue>2</issue><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">30921282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QMH.0000000000000206</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meldon</surname><given-names>SW</given-names></name><name name-style="western"><surname>Mion</surname><given-names>LC</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>RM</given-names></name><name name-style="western"><surname>Drew</surname><given-names>BL</given-names></name><name name-style="western"><surname>Connor</surname><given-names>JT</given-names></name><name name-style="western"><surname>Lewicki</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Bass</surname><given-names>DM</given-names></name><name name-style="western"><surname>Emerman</surname><given-names>CL</given-names></name></person-group><article-title>A brief risk-stratification tool to predict repeat emergency department visits and hospitalizations in older patients discharged from the emergency department</article-title><source>Acad Emerg Med</source><year>2003</year><volume>10</volume><issue>3</issue><fpage>224</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">12615588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1553-2712.2003.tb01996.x</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schummers</surname><given-names>L</given-names></name><name name-style="western"><surname>Himes</surname><given-names>KP</given-names></name><name name-style="western"><surname>Bodnar</surname><given-names>LM</given-names></name><name name-style="western"><surname>Hutcheon</surname><given-names>JA</given-names></name></person-group><article-title>Predictor characteristics necessary for building a clinically useful risk prediction model: a simulation study</article-title><source>BMC Med Res Methodol</source><year>2016</year><volume>16</volume><issue>1</issue><fpage>123</fpage><pub-id pub-id-type="pmid">27655140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12874-016-0223-2</pub-id><pub-id pub-id-type="pmcid">PMC5031287</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prichard</surname><given-names>D</given-names></name><name name-style="western"><surname>Norton</surname><given-names>C</given-names></name><name name-style="western"><surname>Bharucha</surname><given-names>AE</given-names></name></person-group><article-title>Management of opioid-induced constipation</article-title><source>British Journal of Nursing</source><year>2016</year><volume>25</volume><issue>10</issue><fpage>S4</fpage><lpage>S11</lpage><pub-id pub-id-type="pmid">27231750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12968/bjon.2016.25.10.S4</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farmer</surname><given-names>AD</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>AM</given-names></name><name name-style="western"><surname>Chiarioni</surname><given-names>G</given-names></name><name name-style="western"><surname>De Giorgio</surname><given-names>R</given-names></name><name name-style="western"><surname>O'Brien</surname><given-names>T</given-names></name><name name-style="western"><surname>Morlion</surname><given-names>B</given-names></name><name name-style="western"><surname>Tack</surname><given-names>J</given-names></name></person-group><article-title>Pathophysiology and management of opioid-induced constipation: European expert consensus statement</article-title><source>United Eur Gastroenterol J</source><year>2019</year><volume>7</volume><issue>1</issue><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2050640618818305</pub-id><pub-id pub-id-type="pmcid">PMC6374852</pub-id><pub-id pub-id-type="pmid">30788113</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>CL</given-names></name><name name-style="western"><surname>Holman</surname><given-names>CDAJ</given-names></name><name name-style="western"><surname>Satti</surname><given-names>AG</given-names></name></person-group><article-title>Adverse drug reactions in older Australians, 1981&#8211;2002</article-title><source>Med J Aust</source><year>2005</year><volume>182</volume><issue>6</issue><fpage>267</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">15777140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5694/j.1326-5377.2005.tb06698.x</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crispo</surname><given-names>JAG</given-names></name><name name-style="western"><surname>Thibault</surname><given-names>DP</given-names></name><name name-style="western"><surname>Willis</surname><given-names>AW</given-names></name></person-group><article-title>Adverse drug events as a reason for adult hospitalization: A nationwide readmission study</article-title><source>Ann Pharmacother</source><year>2019</year><volume>53</volume><issue>6</issue><fpage>557</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">30525918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1060028018818571</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>H</given-names></name><name name-style="western"><surname>Bell</surname><given-names>D</given-names></name><name name-style="western"><surname>Molokhia</surname><given-names>M</given-names></name><name name-style="western"><surname>Srishanmuganathan</surname><given-names>J</given-names></name><name name-style="western"><surname>Patel</surname><given-names>M</given-names></name><name name-style="western"><surname>Car</surname><given-names>J</given-names></name><name name-style="western"><surname>Majeed</surname><given-names>A</given-names></name></person-group><article-title>Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998&#8211;2005</article-title><source>BMC Clin Pharmacol</source><year>2007</year><volume>7</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="pmid">17894876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1472-6904-7-9</pub-id><pub-id pub-id-type="pmcid">PMC2093926</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>T-Y</given-names></name><name name-style="western"><surname>Jen</surname><given-names>M-H</given-names></name><name name-style="western"><surname>Bottle</surname><given-names>A</given-names></name><name name-style="western"><surname>Molokhia</surname><given-names>M</given-names></name><name name-style="western"><surname>Aylin</surname><given-names>P</given-names></name><name name-style="western"><surname>Bell</surname><given-names>D</given-names></name><name name-style="western"><surname>Majeed</surname><given-names>A</given-names></name></person-group><article-title>Ten-year trends in hospital admissions for adverse drug reactions in England 1999&#8211;2009</article-title><source>J R Soc Med</source><year>2010</year><volume>103</volume><issue>6</issue><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">20513902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1258/jrsm.2010.100113</pub-id><pub-id pub-id-type="pmcid">PMC2878823</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Holman</surname><given-names>CDAJ</given-names></name><name name-style="western"><surname>Price</surname><given-names>SD</given-names></name><name name-style="western"><surname>Sanfilippo</surname><given-names>FM</given-names></name><name name-style="western"><surname>Preen</surname><given-names>DB</given-names></name><name name-style="western"><surname>Bulsara</surname><given-names>MK</given-names></name></person-group><article-title>Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study</article-title><source>BMJ (Clinical research ed)</source><year>2009</year><volume>338</volume><fpage>a2752</fpage><pub-id pub-id-type="pmid">19129307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.a2752</pub-id><pub-id pub-id-type="pmcid">PMC2615549</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dautzenberg</surname><given-names>L</given-names></name><name name-style="western"><surname>Bretagne</surname><given-names>L</given-names></name><name name-style="western"><surname>Koek</surname><given-names>HL</given-names></name><name name-style="western"><surname>Tsokani</surname><given-names>S</given-names></name><name name-style="western"><surname>Zevgiti</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodondi</surname><given-names>N</given-names></name><name name-style="western"><surname>Scholten</surname><given-names>R</given-names></name><name name-style="western"><surname>Rutjes</surname><given-names>AW</given-names></name><name name-style="western"><surname>Di Nisio</surname><given-names>M</given-names></name><name name-style="western"><surname>Raijmann</surname><given-names>R</given-names></name><etal/></person-group><article-title>Medication review interventions to reduce hospital readmissions in older people</article-title><source>J Am Geriatr Soc</source><year>2021</year><volume>69</volume><issue>6</issue><fpage>1646</fpage><lpage>1658</lpage><pub-id pub-id-type="pmid">33576506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.17041</pub-id><pub-id pub-id-type="pmcid">PMC8247962</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dam</surname><given-names>CS</given-names></name><name name-style="western"><surname>Labuschagne</surname><given-names>HA</given-names></name><name name-style="western"><surname>van Keulen</surname><given-names>K</given-names></name><name name-style="western"><surname>Kramers</surname><given-names>C</given-names></name><name name-style="western"><surname>Kleipool</surname><given-names>EE</given-names></name><name name-style="western"><surname>Hoogendijk</surname><given-names>EO</given-names></name><name name-style="western"><surname>Knol</surname><given-names>W</given-names></name><name name-style="western"><surname>Nanayakkara</surname><given-names>PWB</given-names></name><name name-style="western"><surname>Muller</surname><given-names>M</given-names></name><name name-style="western"><surname>Trappenburg</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department</article-title><source>Eur Geriatr Med</source><year>2022</year><volume>13</volume><issue>4</issue><fpage>849</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">35723840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s41999-022-00664-y</pub-id><pub-id pub-id-type="pmcid">PMC9378326</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lepelley</surname><given-names>M</given-names></name><name name-style="western"><surname>Genty</surname><given-names>C</given-names></name><name name-style="western"><surname>Lecoanet</surname><given-names>A</given-names></name><name name-style="western"><surname>Allenet</surname><given-names>B</given-names></name><name name-style="western"><surname>Bedouch</surname><given-names>P</given-names></name><name name-style="western"><surname>Mallaret</surname><given-names>M-R</given-names></name><name name-style="western"><surname>Gillois</surname><given-names>P</given-names></name><name name-style="western"><surname>Bosson</surname><given-names>J-L</given-names></name></person-group><article-title>Electronic medication regimen complexity index at admission and complications during hospitalization in medical wards: a tool to improve quality of care?</article-title><source>Int J Qual Health Care</source><year>2017</year><volume>30</volume><issue>1</issue><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/intqhc/mzx168</pub-id><pub-id pub-id-type="pmid">29281061</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caamano</surname><given-names>F</given-names></name><name name-style="western"><surname>Pedone</surname><given-names>C</given-names></name><name name-style="western"><surname>Zuccala</surname><given-names>G</given-names></name><name name-style="western"><surname>Carbonin</surname><given-names>P</given-names></name></person-group><article-title>Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population</article-title><source>Arch Gerontol Geriatr</source><year>2005</year><volume>40</volume><issue>1</issue><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">15531022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.archger.2004.05.005</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bisharat</surname><given-names>N</given-names></name><name name-style="western"><surname>Handler</surname><given-names>C</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>N</given-names></name></person-group><article-title>Readmissions to medical wards: Analysis of demographic and socio-medical factors</article-title><source>Eur J Intern Med</source><year>2012</year><volume>23</volume><issue>5</issue><fpage>457</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">22726376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejim.2012.03.004</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Gonsahn</surname><given-names>MD</given-names></name><name name-style="western"><surname>Nerenz</surname><given-names>DR</given-names></name></person-group><article-title>Socioeconomic status and readmissions: evidence from an urban teaching hospital</article-title><source>Health Aff (Millwood)</source><year>2014</year><volume>33</volume><issue>5</issue><fpage>778</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">24799574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1377/hlthaff.2013.0816</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>G</given-names></name><name name-style="western"><surname>Gerdtz</surname><given-names>M</given-names></name><name name-style="western"><surname>Manias</surname><given-names>E</given-names></name><name name-style="western"><surname>Hepworth</surname><given-names>G</given-names></name><name name-style="western"><surname>Dent</surname><given-names>A</given-names></name></person-group><article-title>Socio-demographic and clinical characteristics of re-presentation to an Australian inner-city emergency department: implications for service delivery</article-title><source>BMC Public Health</source><year>2007</year><volume>7</volume><issue>1</issue><fpage>320</fpage><pub-id pub-id-type="pmid">17996112</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2458-7-320</pub-id><pub-id pub-id-type="pmcid">PMC2222161</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Walraven</surname><given-names>C</given-names></name><name name-style="western"><surname>Dhalla</surname><given-names>IA</given-names></name><name name-style="western"><surname>Bell</surname><given-names>C</given-names></name><name name-style="western"><surname>Etchells</surname><given-names>E</given-names></name><name name-style="western"><surname>Stiell</surname><given-names>IG</given-names></name><name name-style="western"><surname>Zarnke</surname><given-names>K</given-names></name><name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name><name name-style="western"><surname>Forster</surname><given-names>AJ</given-names></name></person-group><article-title>Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community</article-title><source>CMAJ</source><year>2010</year><volume>182</volume><issue>6</issue><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">20194559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1503/cmaj.091117</pub-id><pub-id pub-id-type="pmcid">PMC2845681</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donz&#233;</surname><given-names>JD</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MV</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Zimlichman</surname><given-names>E</given-names></name><name name-style="western"><surname>Aujesky</surname><given-names>D</given-names></name><name name-style="western"><surname>Vasilevskis</surname><given-names>EE</given-names></name><name name-style="western"><surname>Kripalani</surname><given-names>S</given-names></name><name name-style="western"><surname>Metlay</surname><given-names>JP</given-names></name><name name-style="western"><surname>Wallington</surname><given-names>T</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>GS</given-names></name><etal/></person-group><article-title>International Validity of the HOSPITAL score to predict 30-day potentially avoidable hospital readmissions</article-title><source>JAMA Intern Med</source><year>2016</year><volume>176</volume><issue>4</issue><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">26954698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2015.8462</pub-id><pub-id pub-id-type="pmcid">PMC5070968</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="other">Belouali A, Bai H, Raja K, Liu S, Ding X, Kharrazi H. Impact of social determinants of health on improving the LACE index for 30-day unplanned readmission prediction. JAMIA Open. 2022;5(2):1&#8211;9.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamiaopen/ooac046</pub-id><pub-id pub-id-type="pmcid">PMC9185729</pub-id><pub-id pub-id-type="pmid">35702627</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sholle</surname><given-names>E</given-names></name><name name-style="western"><surname>Abedian</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharko</surname><given-names>M</given-names></name><name name-style="western"><surname>Turchioe</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ancker</surname><given-names>JS</given-names></name></person-group><article-title>Assessing the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission or death</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><issue>6</issue><fpage>e0235064</fpage><pub-id pub-id-type="pmid">32584879</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0235064</pub-id><pub-id pub-id-type="pmcid">PMC7316307</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obuobi</surname><given-names>S</given-names></name><name name-style="western"><surname>Chua</surname><given-names>RFM</given-names></name><name name-style="western"><surname>Besser</surname><given-names>SA</given-names></name><name name-style="western"><surname>Tabit</surname><given-names>CE</given-names></name></person-group><article-title>Social determinants of health and hospital readmissions: can the HOSPITAL risk score be improved by the inclusion of social factors?</article-title><source>BMC Health Serv Res</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="pmid">33397379</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-020-05989-7</pub-id><pub-id pub-id-type="pmcid">PMC7780407</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>VR</given-names></name><name name-style="western"><surname>Jacobson</surname><given-names>KL</given-names></name><name name-style="western"><surname>Gazmararian</surname><given-names>JA</given-names></name><name name-style="western"><surname>Blake</surname><given-names>SC</given-names></name></person-group><article-title>Does social support help limited-literacy patients with medication adherence? A mixed methods study of patients in the Pharmacy Intervention for Limited Literacy (PILL) study</article-title><source>Patient Educ Couns</source><year>2010</year><volume>79</volume><issue>1</issue><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">19647967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pec.2009.07.002</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="other">Kripalani S, Goggins K, Nwosu S, Schildcrout J, Mixon AS, McNaughton C, McDougald Scott AM, Wallston KA: Medication Nonadherence Before Hospitalization for Acute Cardiac Events. J Health Commun 2015;20 Suppl 2(0):34&#8211;42.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10810730.2015.1080331</pub-id><pub-id pub-id-type="pmcid">PMC4705844</pub-id><pub-id pub-id-type="pmid">26513029</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shallcross</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Becker</surname><given-names>DA</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>D</given-names></name><name name-style="western"><surname>Jurd</surname><given-names>R</given-names></name><name name-style="western"><surname>French</surname><given-names>JA</given-names></name><name name-style="western"><surname>Devinsky</surname><given-names>O</given-names></name><name name-style="western"><surname>Spruill</surname><given-names>TM</given-names></name></person-group><article-title>Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy</article-title><source>Epilepsy Behav</source><year>2015</year><volume>46</volume><fpage>242</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">25847430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yebeh.2015.01.034</pub-id><pub-id pub-id-type="pmcid">PMC4701194</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wisnivesky</surname><given-names>JP</given-names></name><name name-style="western"><surname>Krauskopf</surname><given-names>K</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sofianou</surname><given-names>A</given-names></name><name name-style="western"><surname>Martynenko</surname><given-names>M</given-names></name><name name-style="western"><surname>Halm</surname><given-names>EA</given-names></name><name name-style="western"><surname>Leventhal</surname><given-names>H</given-names></name><name name-style="western"><surname>Federman</surname><given-names>AD</given-names></name></person-group><article-title>The association between language proficiency and outcomes of elderly patients with asthma</article-title><source>Ann Allergy Asthma Immunol</source><year>2012</year><volume>109</volume><issue>3</issue><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">22920072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.anai.2012.06.016</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>